Prostatic Neoplasms - Ontology Report - Rat Genome Database

Submit Data | Help | Video Tutorials | News | Publications | Download | REST API | Citing RGD | Contact

Advanced Search (OLGA)

RGD DISEASE ONTOLOGY - ANNOTATIONS

{{ watchLinkText }}

RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.

Term:	Prostatic Neoplasms	go back to main search page
Accession:	DOID:9002304	browse the term
Definition:	Tumors or cancer of the PROSTATE.
Synonyms:	exact_synonym:	prostate neoplasm; prostate neoplasms; prostatic neoplasm
	primary_id:	MESH:D011471

GViewer not supported for the selected species.

show annotations for term's descendants Sort by:
Rat (1308) Mouse (1305) Human (8718) Chinchilla (1194) Bonobo (1293) Dog (1300) Squirrel (1222) Pig (1264) Green Monkey (1265) Naked Mole-rat (1185) All
Genes (1194)

Prostatic Neoplasms

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

aladin WD repeat nucleoporin

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955458:567,487...577,228
Ensembl chrNW_004955458:567,518...577,372

G

ATP binding cassette subfamily C member 4 (PEL blood group)

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955404:14,700,808...14,927,944
Ensembl chrNW_004955404:14,700,808...14,928,617

G

ATP binding cassette subfamily G member 5

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955441:10,964,588...10,987,771
Ensembl chrNW_004955441:10,964,858...10,986,967

G

ABR activator of RhoGEF and GTPase

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955481:2,503,309...2,710,667
Ensembl chrNW_004955481:2,503,315...2,654,244

G

acetylcholinesterase (Cartwright blood group)

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955573:79,606...85,799
Ensembl chrNW_004955573:80,298...85,799

G

acid phosphatase 3

a positive cis-element in the promoter involved in regulating prostate cell-specific expression of the gene

NCBI chrNW_004955501:6,168,083...6,218,934
Ensembl chrNW_004955501:6,164,152...6,218,967

G

acrosin binding protein

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955413:4,251,608...4,262,095

G

acyl-CoA synthetase long chain family member 4

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955490:6,143,833...6,228,395
Ensembl chrNW_004955490:6,143,833...6,228,452

G

acyl-CoA synthetase medium chain family member 3

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955493:73,306...95,521
Ensembl chrNW_004955493:72,633...96,348

G

activin A receptor type 2A

DNA:polymorphism

NCBI chrNW_004955440:13,849,926...13,931,374
Ensembl chrNW_004955440:13,849,926...13,931,374

G

ADAM metallopeptidase domain 28

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955403:47,304,711...47,409,369
Ensembl chrNW_004955403:47,319,382...47,409,380

G

ADAM metallopeptidase domain 9

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955463:14,545,425...14,646,498
Ensembl chrNW_004955463:14,545,589...14,645,419

G

ADAM metallopeptidase with thrombospondin type 1 motif 8

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955412:31,295,436...31,336,781
Ensembl chrNW_004955412:31,296,051...31,314,835

G

acireductone dioxygenase 1

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955487:3,816,428...3,822,663
Ensembl chrNW_004955487:3,816,428...3,822,663

G

adrenoceptor beta 2

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955415:5,515,157...5,517,198
Ensembl chrNW_004955415:5,515,697...5,516,980

G

anterior gradient 2, protein disulphide isomerase family member

CTD Direct Evidence: marker/mechanism

PMID:17013881 PMID:25237833

NCBI chrNW_004955410:19,984,768...19,995,446
Ensembl chrNW_004955410:19,984,768...19,995,733

G

adenosylhomocysteinase like 2

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955479:10,008,814...10,211,370
Ensembl chrNW_004955479:10,008,891...10,214,868

G

aryl hydrocarbon receptor

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955410:20,428,531...20,459,482
Ensembl chrNW_004955410:20,428,546...20,456,836

G

A-kinase anchoring protein 13

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955416:19,006,206...19,327,523
Ensembl chrNW_004955416:19,009,485...19,247,626

G

AKT serine/threonine kinase 1

CTD Direct Evidence: marker/mechanism

PMID:15682402 PMID:29610475 PMID:33129824

NCBI chrNW_004955538:3,208,711...3,224,386
Ensembl chrNW_004955538:3,208,710...3,229,904

G

AKT serine/threonine kinase 2

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955578:950,258...1,004,438
Ensembl chrNW_004955578:967,593...1,004,438

G

aminolevulinate dehydratase

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955419:14,093,010...14,104,376
Ensembl chrNW_004955419:14,093,010...14,104,545

G

aldehyde dehydrogenase 1 family member A2

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955450:16,406,578...16,453,048
Ensembl chrNW_004955450:16,406,436...16,453,180

G

arachidonate 12-lipoxygenase, 12R type

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955467:8,876,186...8,887,980
Ensembl chrNW_004955467:8,876,027...8,888,033

G

arachidonate 5-lipoxygenase

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955546:2,495,226...2,550,909
Ensembl chrNW_004955546:2,494,819...2,550,909

G

arachidonate epidermal lipoxygenase 3

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955467:8,844,805...8,869,230
Ensembl chrNW_004955467:8,844,805...8,869,964

G

alpha-methylacyl-CoA racemase

mRNA, protein:increased expression:prostate gland
CTD Direct Evidence: marker/mechanism

PMID:17173048 PMID:20003233 PMID:22919386 PMID:24763052

NCBI chrNW_004955426:19,570,179...19,580,920
Ensembl chrNW_004955426:19,570,070...19,580,818

G

ANTXR cell adhesion molecule 2

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955433:4,212,729...4,345,611
Ensembl chrNW_004955433:4,212,729...4,345,066

G

annexin A1

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955512:5,686,508...5,703,645

G

annexin A3

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955433:2,981,113...3,043,894
Ensembl chrNW_004955433:2,977,513...3,044,446

G

annexin A4

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955424:15,323,604...15,389,136
Ensembl chrNW_004955424:15,321,990...15,389,136

G

amine oxidase copper containing 1

NCBI chrNW_004955491:5,316,482...5,326,262
Ensembl chrNW_004955491:5,316,476...5,326,305

G

aldehyde oxidase 1

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955403:827,538...875,856
Ensembl chrNW_004955403:828,066...872,218

G

APC regulator of WNT signaling pathway

CTD Direct Evidence: marker/mechanism

PMID:17363566 PMID:29610475

NCBI chrNW_004955418:2,567,804...2,675,062
Ensembl chrNW_004955418:2,566,975...2,674,832

G

apurinic/apyrimidinic endodeoxyribonuclease 1

susceptibility

CTD Direct Evidence: marker/mechanism
protein:increased expression, altered localization:prostate, cytoplasm

PMID:11309329 PMID:16406883 PMID:29541389

RGD:2315665 RGD:2315666

NCBI chrNW_004955550:1,273,170...1,275,843
Ensembl chrNW_004955550:1,273,284...1,279,743

G

adaptor protein, phosphotyrosine interacting with PH domain and leucine zipper 2

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955405:39,503,020...39,540,069
Ensembl chrNW_004955405:39,503,020...39,540,335

G

androgen receptor

onset

CTD Direct Evidence: marker/mechanism|therapeutic

PMID:11742035 PMID:12237244 PMID:15389811 PMID:15790600 PMID:16266977 More...

NCBI chrNW_004955475:7,013,960...7,192,473
Ensembl chrNW_004955475:7,013,960...7,186,069

G

amphiregulin

protein:increased expression:prostate gland

NCBI chrNW_004955474:680,212...689,021
Ensembl chrNW_004955474:680,204...689,088

G

arginase 2

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955466:2,549,557...2,577,060
Ensembl chrNW_004955466:2,549,557...2,577,060

G

Rho guanine nucleotide exchange factor 5

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955491:539,040...561,494
Ensembl chrNW_004955491:545,342...563,543

G

AT-rich interaction domain 1A

CTD Direct Evidence: marker/mechanism

PMID:29610475 PMID:29662167

NCBI chrNW_004955452:6,068,631...6,120,759
Ensembl chrNW_004955452:6,068,631...6,120,759

G

AT-rich interaction domain 2

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955500:4,998,555...5,177,180
Ensembl chrNW_004955500:4,998,555...5,175,776

G

AT-rich interaction domain 4A

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955466:12,017,588...12,087,667

G

ARL6 interacting reticulophagy regulator 1

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955442:2,540,676...2,550,531
Ensembl chrNW_004955442:2,540,676...2,550,531

G

ASH1 like histone lysine methyltransferase

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955545:1,778,905...1,950,656
Ensembl chrNW_004955545:1,778,905...1,923,104

G

ankyrin repeat, SAM and basic leucine zipper domain containing 1

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955432:23,059,462...23,119,421
Ensembl chrNW_004955432:23,060,657...23,119,427

G

activating transcription factor 3

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955406:4,875,672...4,889,173
Ensembl chrNW_004955406:4,875,613...4,889,242

G

ATM serine/threonine kinase

protein:increased expression:prostate gland
CTD Direct Evidence: marker/mechanism

PMID:14983937 PMID:17502119 PMID:25415046 PMID:26098866 PMID:29610475

NCBI chrNW_004955412:10,422,753...10,531,406
Ensembl chrNW_004955412:10,426,135...10,530,545

G

ATPase copper transporting beta

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955431:5,228,395...5,297,120
Ensembl chrNW_004955431:5,229,126...5,269,616

G

ATR serine/threonine kinase

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955508:3,337,036...3,440,313
Ensembl chrNW_004955508:3,337,432...3,440,257

G

aurora kinase A

CTD Direct Evidence: marker/mechanism
protein:increased expression:prostate gland

PMID:15754349 PMID:16707419 PMID:17898866

RGD:2293877 RGD:2293883

NCBI chrNW_004955445:2,831,073...2,853,151
Ensembl chrNW_004955445:2,831,157...2,853,357

G

aurora kinase B

NCBI chrNW_004955467:8,715,387...8,720,889
Ensembl chrNW_004955467:8,715,136...8,723,932

G

alpha-2-glycoprotein 1, zinc-binding

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955573:902,153...910,481
Ensembl chrNW_004955573:899,798...912,272

G

beta-2-microglobulin

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955416:11,205,503...11,211,325
Ensembl chrNW_004955416:11,204,849...11,215,568

G

beta-1,4-galactosyltransferase 4

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955427:18,964,578...18,982,090
Ensembl chrNW_004955427:18,963,396...18,985,479

G

BCL2 associated agonist of cell death

CTD Direct Evidence: marker/mechanism

PMID:17542986 PMID:17607361 PMID:19593445

NCBI chrNW_004955422:20,795,585...20,809,039
Ensembl chrNW_004955422:20,795,676...20,809,245

G

BRCA1 associated deubiquitinase 1

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955430:2,391,970...2,400,645
Ensembl chrNW_004955430:2,390,524...2,400,645

G

BCL2 associated X, apoptosis regulator

CTD Direct Evidence: marker/mechanism

PMID:17542986 PMID:18317887

NCBI chrNW_004955559:1,695,960...1,700,246
Ensembl chrNW_004955559:1,695,960...1,700,244

G

bromodomain adjacent to zinc finger domain 2A

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955458:4,149,610...4,186,647
Ensembl chrNW_004955458:4,151,886...4,170,641

G

BCAR1 scaffold protein, Cas family member

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955484:2,223,306...2,258,444
Ensembl chrNW_004955484:2,227,337...2,260,565

G

brain enriched myelin associated protein 1

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955445:4,951,645...5,049,925
Ensembl chrNW_004955445:4,951,433...5,055,238

G

BCL2 apoptosis regulator

CTD Direct Evidence: marker/mechanism

PMID:16733517 PMID:18317887

NCBI chrNW_004955402:46,911,125...47,084,214
Ensembl chrNW_004955402:46,916,266...47,084,485

G

bone gamma-carboxyglutamate protein

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955545:2,381,091...2,382,114
Ensembl chrNW_004955545:2,381,156...2,381,978

G

bone morphogenetic protein 7

CTD Direct Evidence: marker/mechanism

PMID:17013881 PMID:19283074

NCBI chrNW_004955445:2,154,057...2,235,594
Ensembl chrNW_004955445:2,153,170...2,235,795

G

bone morphogenetic protein receptor type 1B

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955405:5,408,171...5,784,930
Ensembl chrNW_004955405:5,700,162...5,787,957

G

BCL2 interacting protein 3

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955477:9,621,812...9,630,406
Ensembl chrNW_004955477:9,621,812...9,638,099

G

B-Raf proto-oncogene, serine/threonine kinase

CTD Direct Evidence: marker/mechanism

PMID:25735316 PMID:29610475

NCBI chrNW_004955494:2,567,238...2,712,708

G

BRCA1 DNA repair associated

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955451:16,819,463...16,870,780
Ensembl chrNW_004955451:16,819,023...16,855,528

G

BRCA2 DNA repair associated

ClinVar Annotator: match by term: Prostate neoplasm

PMID:21120943 PMID:24448499 PMID:25741868 PMID:26689913 PMID:28492532 More...

NCBI chrNW_004955431:13,449,287...13,526,878
Ensembl chrNW_004955431:13,449,543...13,527,432

G

bromodomain containing 4

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955495:7,959,033...7,989,216
Ensembl chrNW_004955495:7,957,510...7,988,498

G

bromodomain and PHD finger containing 1

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955561:1,260,237...1,275,953
Ensembl chrNW_004955561:1,259,700...1,276,015

G

basigin (Ok blood group)

NCBI chrNW_004955495:7,148,806...7,156,296

G

BTG anti-proliferation factor 2

protein:decreased expression:prostate gland

NCBI chrNW_004955406:39,303,221...39,307,308
Ensembl chrNW_004955406:39,303,175...39,308,778

G

calreticulin

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955415:31,985,147...31,989,372
Ensembl chrNW_004955415:31,985,147...31,989,372

G

calcium/calmodulin dependent protein kinase kinase 2

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955482:7,000,010...7,029,623
Ensembl chrNW_004955482:7,000,010...7,029,623

G

calpain small subunit 1

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955468:2,446,631...2,454,369
Ensembl chrNW_004955468:2,447,111...2,452,982

G

coactivator associated arginine methyltransferase 1

protein:increased expression:prostate gland

NCBI chrNW_004955495:1,983,599...2,002,174
Ensembl chrNW_004955495:1,983,599...2,002,174

G

caspase 3

NCBI chrNW_004955403:24,315,712...24,326,271

G

caspase 9

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955527:2,613,691...2,630,217
Ensembl chrNW_004955527:2,613,683...2,629,738

G

castor zinc finger 1

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955486:2,923,239...2,975,835

G

caveolin 1

disease_progression

CTD Direct Evidence: marker/mechanism

PMID:11751529 PMID:15948133 PMID:17786030 PMID:22159333

RGD:2289102 RGD:2289111

NCBI chrNW_004955432:22,258,262...22,292,403
Ensembl chrNW_004955432:22,258,250...22,292,403

G

caveolin 2

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955432:22,240,041...22,242,200

G

carbonyl reductase 1

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955407:35,351,601...35,354,510

G

chromobox 1

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955451:13,066,628...13,083,693
Ensembl chrNW_004955451:13,066,628...13,083,693

G

coiled-coil alpha-helical rod protein 1

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955583:979,138...989,267
Ensembl chrNW_004955583:978,825...989,793

G

cyclin A2

severity

protein:increased expression:prostate gland

NCBI chrNW_004955428:18,725,969...18,732,478
Ensembl chrNW_004955428:18,726,062...18,732,211

G

cyclin D1

disease_progression

mRNA, protein:decreased expression:prostate gland
CTD Direct Evidence: marker/mechanism

PMID:14968434 PMID:17606477

NCBI chrNW_004955422:16,449,921...16,462,676
Ensembl chrNW_004955422:16,448,770...16,463,300

G

cyclin D2

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955413:2,083,351...2,108,450
Ensembl chrNW_004955413:2,083,351...2,103,430

G

cyclin E1

disease_progression

mRNA, protein:increased expression:prostate gland

NCBI chrNW_004955468:7,803,610...7,814,872
Ensembl chrNW_004955468:7,803,346...7,814,872

G

cyclin H

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955418:23,790,398...23,807,509
Ensembl chrNW_004955418:23,790,001...23,807,702

G

CD276 molecule

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955450:3,884,437...3,896,416

G

CD9 molecule

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955413:3,891,874...3,924,065
Ensembl chrNW_004955413:3,891,874...3,928,119

G

cell division cycle 25B

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955415:14,637,295...14,647,181
Ensembl chrNW_004955415:14,629,132...14,650,116

G

cell division cycle 27

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955478:9,927,871...10,002,020
Ensembl chrNW_004955478:9,927,871...10,002,020

G

cadherin 1

CTD Direct Evidence: marker/mechanism

PMID:16813949 PMID:22581815 PMID:29295717 PMID:29610475

NCBI chrNW_004955484:7,782,409...7,861,082
Ensembl chrNW_004955484:7,782,772...7,860,967

G

cadherin 12

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955426:9,652,418...10,610,762
Ensembl chrNW_004955426:9,651,959...10,059,415

G

cadherin 13

CTD Direct Evidence: marker/mechanism

PMID:17288544 PMID:18264096

NCBI chrNW_004955564:407,120...1,549,880
Ensembl chrNW_004955564:408,730...1,426,841

G

cyclin dependent kinase 1

PMID:17460776 PMID:17575168

RGD:2711357 RGD:2756028

NCBI chrNW_004955425:14,210,681...14,226,474
Ensembl chrNW_004955425:14,210,680...14,226,474

G

cyclin dependent kinase 12

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955451:14,244,392...14,345,885
Ensembl chrNW_004955451:14,244,978...14,309,689

G

cyclin dependent kinase 2 associated protein 2

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955422:17,981,267...17,983,480
Ensembl chrNW_004955422:17,981,267...17,984,517

G

cyclin dependent kinase inhibitor 1A

CTD Direct Evidence: marker/mechanism

PMID:12727815 PMID:15598783

NCBI chrNW_004955437:6,254,638...6,261,278
Ensembl chrNW_004955437:6,254,309...6,261,479

G

cyclin dependent kinase inhibitor 1B

severity

CTD Direct Evidence: marker/mechanism|therapeutic
protein:decreased expression:prostate gland

PMID:12727815 PMID:18006855 PMID:18415709 PMID:20932324 PMID:29610475

RGD:2293591 RGD:2293596

NCBI chrNW_004955413:9,615,542...9,620,542
Ensembl chrNW_004955413:9,615,542...9,620,542

G

CUGBP Elav-like family member 2

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955421:27,064,497...27,374,850
Ensembl chrNW_004955421:26,992,734...27,374,850

G

centromere protein F

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955406:3,225,788...3,273,037
Ensembl chrNW_004955406:3,223,993...3,273,714

G

chromodomain helicase DNA binding protein 1

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955418:14,200,618...14,268,361
Ensembl chrNW_004955418:14,200,617...14,268,361

G

chromodomain helicase DNA binding protein 3

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955467:9,024,112...9,050,062
Ensembl chrNW_004955467:9,029,265...9,050,718

G

chromodomain helicase DNA binding protein 6

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955445:15,360,074...15,576,410
Ensembl chrNW_004955445:15,360,025...15,560,988

G

chromodomain helicase DNA binding protein 7

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955444:17,859,999...18,067,623
Ensembl chrNW_004955444:17,858,771...18,067,248

G

checkpoint kinase 2

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955455:2,969,113...3,008,004
Ensembl chrNW_004955455:2,969,270...3,003,173

G

carbohydrate sulfotransferase 14

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955416:7,391,281...7,393,137
Ensembl chrNW_004955416:7,391,282...7,392,355

G

component of inhibitor of nuclear factor kappa B kinase complex

protein:increased expression:prostate gland

NCBI chrNW_004955507:6,066,026...6,102,066
Ensembl chrNW_004955507:6,067,203...6,102,001

G

CDKN1A interacting zinc finger protein 1

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955570:716,124...732,551
Ensembl chrNW_004955570:707,637...732,980

G

claudin 7

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955467:9,652,093...9,654,291
Ensembl chrNW_004955467:9,652,093...9,654,291

G

claudin 9

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955442:14,326,705...14,328,150
Ensembl chrNW_004955442:14,327,140...14,327,793

G

chloride intracellular channel 4

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955452:4,479,783...4,534,115
Ensembl chrNW_004955452:4,479,783...4,534,115

G

CLPTM1 like

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955504:677,824...695,660
Ensembl chrNW_004955504:677,772...695,660

G

clusterin

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955403:50,160,598...50,175,876
Ensembl chrNW_004955403:50,160,598...50,175,876

G

calponin 3

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955435:80,185...89,216
Ensembl chrNW_004955435:80,185...89,766

G

CCR4-NOT transcription complex subunit 3

CTD Direct Evidence: marker/mechanism

PMID:29610475 PMID:29662167

NCBI chrNW_004955604:109,522...122,001
Ensembl chrNW_004955604:109,340...122,001

G

collagen type XV alpha 1 chain

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955419:26,577,172...26,687,750
Ensembl chrNW_004955419:26,574,835...26,687,803

G

collagen type V alpha 1 chain

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955513:3,533,612...3,660,605
Ensembl chrNW_004955513:3,533,614...3,658,161

G

collagen type V alpha 3 chain

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955495:1,347,171...1,386,683

G

catechol-O-methyltransferase

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955442:18,130,282...18,152,153
Ensembl chrNW_004955442:18,130,987...18,137,412

G

copine 3

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955417:4,115,298...4,146,878
Ensembl chrNW_004955417:4,115,308...4,145,939

G

cAMP responsive element binding protein 3 like 4

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955545:563,710...569,224
Ensembl chrNW_004955545:564,193...568,942

G

CREB binding protein

CTD Direct Evidence: marker/mechanism

PMID:15378487 PMID:25735316

NCBI chrNW_004955442:13,559,496...13,691,913
Ensembl chrNW_004955442:13,559,496...13,692,004

G

cellular repressor of E1A stimulated genes 1

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955462:9,440,019...9,451,875
Ensembl chrNW_004955462:9,439,987...9,455,268

G

crystallin alpha B

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955412:13,626,018...13,629,495
Ensembl chrNW_004955412:13,625,363...13,640,426

G

crystallin lambda 1

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955497:1,183,707...1,316,720
Ensembl chrNW_004955497:1,182,115...1,292,721

G

colony stimulating factor 1 receptor

protein:increased expression:prostate gland

NCBI chrNW_004955415:4,434,486...4,462,505
Ensembl chrNW_004955415:4,434,453...4,461,751

G

cysteine and glycine rich protein 1

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955406:37,595,481...37,615,384
Ensembl chrNW_004955406:37,595,420...37,615,612

G

cystatin E/M

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955422:19,326,302...19,327,449
Ensembl chrNW_004955422:19,313,352...19,327,360

G

C-terminal binding protein 2

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955477:2,922,334...3,082,088
Ensembl chrNW_004955477:2,922,334...3,082,406

G

cytotoxic T-lymphocyte associated protein 4

NCBI chrNW_004955457:11,028,707...11,034,898
Ensembl chrNW_004955457:11,028,698...11,073,460

G

catenin beta 1

CTD Direct Evidence: marker/mechanism

PMID:17363566 PMID:17638904 PMID:29610475

NCBI chrNW_004955420:29,030,716...29,047,447
Ensembl chrNW_004955420:29,030,716...29,047,449

G

cathepsin B

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955403:53,086,236...53,100,217
Ensembl chrNW_004955403:53,085,574...53,093,809

G

cathepsin D

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955422:13,576,315...13,584,267
Ensembl chrNW_004955422:13,576,202...13,584,298

G

cullin 3

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955453:9,546,554...9,629,976
Ensembl chrNW_004955453:9,564,522...9,629,976

G

C-X3-C motif chemokine ligand 1

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955433:15,023,272...15,034,650
Ensembl chrNW_004955433:15,023,050...15,034,711

G

C-X-C motif chemokine ligand 12

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955546:1,929,269...1,941,690
Ensembl chrNW_004955546:1,929,269...1,941,690

G

C-X-C motif chemokine ligand 8

CTD Direct Evidence: marker/mechanism

PMID:16606632 PMID:17606477

NCBI chrNW_004955474:247,326...250,355
Ensembl chrNW_004955474:241,501...250,643

G

DAB2 interacting protein

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955419:6,229,437...6,416,619
Ensembl chrNW_004955419:6,228,591...6,416,402

G

dystroglycan 1

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955532:1,446,553...1,465,310
Ensembl chrNW_004955532:1,397,900...1,466,312

G

DDB1 and CUL4 associated factor 6

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955462:9,036,710...9,176,981
Ensembl chrNW_004955462:9,037,118...9,176,713

G

discoidin domain receptor tyrosine kinase 1

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955583:820,893...838,515
Ensembl chrNW_004955583:820,931...841,654

G

delta 4-desaturase, sphingolipid 1

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955520:1,139,568...1,143,149
Ensembl chrNW_004955520:1,135,563...1,143,192

G

dihydrodiol dehydrogenase

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955559:1,706,950...1,719,220
Ensembl chrNW_004955559:1,705,731...1,719,834

G

DExH-box helicase 30

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955420:24,537,608...24,549,771
Ensembl chrNW_004955420:24,537,608...24,561,293

G

diablo IAP-binding mitochondrial protein

CTD Direct Evidence: therapeutic

NCBI chrNW_004955482:6,354,502...6,364,424
Ensembl chrNW_004955482:6,354,146...6,365,344

G

DnaJ heat shock protein family (Hsp40) member C10

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955403:14,681,015...14,717,060
Ensembl chrNW_004955403:14,680,852...14,717,060

G

DnaJ heat shock protein family (Hsp40) member C3

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955404:14,361,540...14,412,533
Ensembl chrNW_004955404:14,360,832...14,412,533

G

deoxyribonuclease 1 like 2

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955442:15,028,168...15,031,110
Ensembl chrNW_004955442:15,028,168...15,031,110

G

DNA methyltransferase 1

treatment

CTD Direct Evidence: marker/mechanism

PMID:20584988 PMID:22581815 PMID:24038143

RGD:9588628 RGD:9588671

NCBI chrNW_004955495:1,465,529...1,505,379
Ensembl chrNW_004955495:1,465,480...1,505,462

G

DNA methyltransferase 3 beta

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955422:28,380,595...28,427,012
Ensembl chrNW_004955422:28,380,591...28,421,301

G

DOT1 like histone lysine methyltransferase

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955495:5,907,486...5,958,241
Ensembl chrNW_004955495:5,909,880...5,959,027

G

ELL associated factor 2

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955427:21,171,900...21,204,138
Ensembl chrNW_004955427:21,172,009...21,204,051

G

EGF containing fibulin extracellular matrix protein 2

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955422:19,463,090...19,470,605
Ensembl chrNW_004955422:19,463,987...19,470,605

G

epidermal growth factor

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955496:325,954...401,430
Ensembl chrNW_004955496:328,075...401,569

G

epidermal growth factor receptor

CTD Direct Evidence: marker/mechanism|therapeutic

PMID:15302576 PMID:17136230 PMID:17914592

NCBI chrNW_004955456:321,222...456,431

G

early growth response 1

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955418:2,001,509...2,005,269
Ensembl chrNW_004955418:2,002,699...2,005,007

G

EH domain binding protein 1

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955424:21,151,473...21,500,044
Ensembl chrNW_004955424:21,152,422...21,500,224

G

ETS homologous factor

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955422:11,599,245...11,640,828
Ensembl chrNW_004955422:11,598,884...11,641,396

G

EI24 autophagy associated transmembrane protein

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955412:26,574,814...26,586,154
Ensembl chrNW_004955412:26,574,866...26,585,161

G

eukaryotic translation initiation factor 2 alpha kinase 2

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955441:4,908,318...4,944,343

G

eukaryotic translation initiation factor 3 subunit A

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955431:23,542,842...23,578,892
Ensembl chrNW_004955431:23,543,838...23,578,757

G

eukaryotic translation initiation factor 3 subunit H

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955417:22,757,781...22,846,349
Ensembl chrNW_004955417:22,754,395...22,846,618

G

elaC ribonuclease Z 2

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955467:4,406,947...4,428,769
Ensembl chrNW_004955467:4,406,824...4,427,780

G

epithelial membrane protein 1

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955413:10,062,621...10,081,551
Ensembl chrNW_004955413:10,062,635...10,081,733

G

epithelial membrane protein 3 (MAM blood group)

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955559:2,117,200...2,121,366
Ensembl chrNW_004955559:2,117,200...2,121,366

G

ectonucleotide pyrophosphatase/phosphodiesterase family member 5

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955437:11,195,846...11,204,000
Ensembl chrNW_004955437:11,195,391...11,204,728

G

epithelial cell adhesion molecule

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955441:14,155,084...14,167,584
Ensembl chrNW_004955441:14,155,082...14,169,161

G

epoxide hydrolase 1

CTD Direct Evidence: marker/mechanism

PMID:17919073 PMID:21716162 PMID:24763052

NCBI chrNW_004955520:116,363...142,983
Ensembl chrNW_004955520:116,363...128,665

G

EPS8 signaling adaptor L3

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955435:13,261,730...13,277,117
Ensembl chrNW_004955435:13,261,429...13,274,613

G

erb-b2 receptor tyrosine kinase 2

CTD Direct Evidence: marker/mechanism

PMID:11222871 PMID:16984552 PMID:17363613

NCBI chrNW_004955451:14,442,816...14,456,009
Ensembl chrNW_004955451:14,442,816...14,459,379

G

erb-b2 receptor tyrosine kinase 3

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955458:3,683,126...3,701,752
Ensembl chrNW_004955458:3,683,126...3,702,978

G

ERCC excision repair 1, endonuclease non-catalytic subunit

disease_progression

NCBI chrNW_004955555:2,393,510...2,430,180
Ensembl chrNW_004955555:2,393,278...2,406,582

G

ERCC excision repair 2, TFIIH core complex helicase subunit

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955555:2,355,005...2,369,599
Ensembl chrNW_004955555:2,355,005...2,369,599

G

ETS2 repressor factor

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955555:654,945...661,097
Ensembl chrNW_004955555:654,414...665,277

G

ETS transcription factor ERG

CTD Direct Evidence: marker/mechanism

PMID:17173048 PMID:18798265 PMID:19396168 PMID:25735316 PMID:27223260 More...

NCBI chrNW_004955407:37,372,471...37,613,674
Ensembl chrNW_004955407:37,369,641...37,542,751

G

endoplasmic reticulum protein 29

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955482:8,572,227...8,579,589
Ensembl chrNW_004955482:8,572,227...8,579,946

G

endoplasmic reticulum protein 44

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955419:25,584,404...25,665,590
Ensembl chrNW_004955419:25,584,404...25,665,590

G

estrogen receptor 1

CTD Direct Evidence: marker/mechanism

PMID:16220300 PMID:17176215

NCBI chrNW_004955439:9,588,631...9,953,606
Ensembl chrNW_004955439:9,588,201...9,963,353

G

estrogen receptor 2

disease_progression

CTD Direct Evidence: marker/mechanism|therapeutic
mRNA:decreased expression:prostate gland

PMID:15046698 PMID:16220300 PMID:16921512 PMID:17132221 PMID:17639508 More...

NCBI chrNW_004955466:5,587,003...5,644,765
Ensembl chrNW_004955466:5,575,088...5,638,946

G

ETS variant transcription factor 1

CTD Direct Evidence: marker/mechanism

PMID:17173048 PMID:17671502 PMID:27783944

NCBI chrNW_004955410:17,445,496...17,535,856
Ensembl chrNW_004955410:17,445,496...17,535,856

G

ETS variant transcription factor 4

CTD Direct Evidence: marker/mechanism

PMID:17173048 PMID:27783944

NCBI chrNW_004955451:16,965,404...16,976,503
Ensembl chrNW_004955451:16,965,125...16,976,127

G

ETS variant transcription factor 5

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955420:21,503,820...21,576,539
Ensembl chrNW_004955420:21,509,248...21,576,599

G

EWS RNA binding protein 1

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955455:3,571,025...3,599,975
Ensembl chrNW_004955455:3,571,025...3,601,975

G

enhancer of zeste 2 polycomb repressive complex 2 subunit

CTD Direct Evidence: marker/mechanism

PMID:17003774 PMID:17173048 PMID:21903722

NCBI chrNW_004955491:4,215,353...4,292,229
Ensembl chrNW_004955491:4,215,298...4,292,235

G

ezrin

CTD Direct Evidence: marker/mechanism

PMID:17013881 PMID:17566973 PMID:24763052

NCBI chrNW_004955439:3,701,722...3,740,345
Ensembl chrNW_004955439:3,703,013...3,740,345

G

Fas associated factor family member 2

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955408:28,737,597...28,797,143
Ensembl chrNW_004955408:28,737,279...28,797,564

G

Fas cell surface death receptor

NCBI chrNW_004955425:3,961,671...3,987,513
Ensembl chrNW_004955425:3,961,013...3,987,455

G

Fas ligand

CTD Direct Evidence: therapeutic

NCBI chrNW_004955406:13,098,479...13,107,045
Ensembl chrNW_004955406:13,098,662...13,107,389

G

fibulin 1

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955413:29,837,134...29,911,313
Ensembl chrNW_004955413:29,837,134...29,912,222

G

fibulin 5

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955438:14,073,927...14,144,644
Ensembl chrNW_004955438:14,071,410...14,145,070

G

F-box protein 44

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955486:2,204,470...2,210,604
Ensembl chrNW_004955486:2,204,470...2,210,604

G

fibroblast growth factor 10

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955446:18,163,117...18,244,840
Ensembl chrNW_004955446:18,163,117...18,245,199

G

fibroblast growth factor 2

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955428:17,840,554...17,894,779
Ensembl chrNW_004955428:17,840,628...17,894,773

G

fibroblast growth factor 6

mRNA,protein:increased expression:prostate

NCBI chrNW_004955413:2,246,965...2,257,883
Ensembl chrNW_004955413:2,246,965...2,257,883

G

fibroblast growth factor 8

disease_progression

mRNA,protein:increased expression:prostate:isoforms FGF8a and FGF8e
mRNA:decreased expression:prostate:expression negatively correlated with Gleason grade (p = 0.02)
protein:increased expression:prostate:expression of isoform FGF8b significantly associated with both stage (P=0.0004) and grade (P<0.0001)

PMID:10343609 PMID:11406643 PMID:12778074

RGD:2289338 RGD:2289340 RGD:2289343

NCBI chrNW_004955485:8,517,412...8,521,732
Ensembl chrNW_004955485:8,517,412...8,521,770

G

fibroblast growth factor receptor 4

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955408:29,370,480...29,383,531
Ensembl chrNW_004955408:29,370,468...29,383,971

G

fragile histidine triad diadenosine triphosphatase

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955430:221,518...508,094

G

fms related receptor tyrosine kinase 1

DNA:hypermethylation:promoter:methylated in 24/63 (38.1%) of cancer samples but 0/13 (0%) of benign prostate samples
protein:increased expression:prostate:expression in 15/15 (100%) of tumors examined, levels increased in neoplastic tissue relative to adjacent benign tissue

PMID:10475375 PMID:12824880

RGD:2289936 RGD:2289963

NCBI chrNW_004955497:7,653,309...7,831,737
Ensembl chrNW_004955497:7,653,248...7,831,472

G

fms related receptor tyrosine kinase 3

NCBI chrNW_004955497:7,357,533...7,441,215
Ensembl chrNW_004955497:7,357,212...7,461,439

G

forkhead box A1

CTD Direct Evidence: marker/mechanism

PMID:22610119 PMID:26457646 PMID:29295717 PMID:29610475 PMID:32690948

NCBI chrNW_004955409:23,598,127...23,599,827
Ensembl chrNW_004955409:23,598,127...23,599,461

G

forkhead box A3

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955574:293,344...301,955
Ensembl chrNW_004955574:293,344...302,002

G

forkhead box O1

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955431:5,797,359...5,890,758

G

forkhead box P4

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955437:8,029,346...8,056,243
Ensembl chrNW_004955437:8,014,939...8,057,033

G

frizzled class receptor 4

protein:increased expression:prostate gland

NCBI chrNW_004955414:6,094,585...6,103,910
Ensembl chrNW_004955414:6,094,585...6,098,865

G

growth arrest and DNA damage inducible alpha

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955423:23,656,516...23,658,367
Ensembl chrNW_004955423:23,656,458...23,658,367

G

polypeptide N-acetylgalactosaminyltransferase 3

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955449:8,365,951...8,406,988
Ensembl chrNW_004955449:8,379,164...8,406,988

G

glucosaminyl (N-acetyl) transferase 1

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955512:2,827,321...2,857,777
Ensembl chrNW_004955512:2,827,321...2,857,777

G

growth differentiation factor 15

CTD Direct Evidence: marker/mechanism

PMID:16775185 PMID:23996089

NCBI chrNW_004955524:3,123,513...3,125,642
Ensembl chrNW_004955524:3,123,760...3,125,621

G

gamma-glutamyltransferase 1

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955455:8,082,578...8,099,523

G

growth hormone receptor

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955426:26,553,509...26,873,619
Ensembl chrNW_004955426:26,689,581...26,871,684

G

growth hormone releasing hormone receptor

disease_progression

DNA:transition:cds:p.D60G (mouse)

NCBI chrNW_004955410:32,084,210...32,114,844
Ensembl chrNW_004955410:32,102,367...32,115,080

G

gap junction protein alpha 1

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955436:3,612,533...3,618,095
Ensembl chrNW_004955436:3,612,533...3,618,095

G

G protein subunit gamma 5

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955423:9,388,501...9,393,287

G

glycine N-methyltransferase

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955437:8,944,288...8,946,642
Ensembl chrNW_004955437:8,944,047...8,946,642

G

golgin A4

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955421:4,130,040...4,251,968
Ensembl chrNW_004955421:4,131,653...4,243,651

G

glutathione peroxidase 3

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955408:2,622,162...2,629,088
Ensembl chrNW_004955408:2,622,741...2,629,032

G

growth factor receptor bound protein 7

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955451:14,463,032...14,470,392
Ensembl chrNW_004955451:14,464,541...14,474,070

G

growth regulating estrogen receptor binding 1

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955487:6,032,774...6,112,715
Ensembl chrNW_004955487:6,062,326...6,112,856

G

glyoxylate and hydroxypyruvate reductase

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955419:29,032,591...29,044,046
Ensembl chrNW_004955419:29,032,600...29,044,257

G

gastrin releasing peptide receptor

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955519:2,032,500...2,063,292
Ensembl chrNW_004955519:2,032,500...2,063,292

G

glycogen synthase kinase 3 beta

CTD Direct Evidence: marker/mechanism

PMID:16421604 PMID:25246272

NCBI chrNW_004955427:19,489,972...19,671,137
Ensembl chrNW_004955427:19,495,422...19,671,137

G

glutathione S-transferase C-terminal domain containing

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955496:3,447,400...3,564,540
Ensembl chrNW_004955496:3,444,310...3,565,414

G

glutathione S-transferase kappa 1

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955494:383,107...387,483
Ensembl chrNW_004955494:383,341...387,630

G

glutathione S-transferase mu 3

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955435:13,253,947...13,256,965
Ensembl chrNW_004955435:13,253,947...13,256,965

G

glutathione S-transferase pi 1

CTD Direct Evidence: marker/mechanism

PMID:11196146 PMID:15538743 PMID:17173048 PMID:19223546 PMID:22581815

NCBI chrNW_004955422:17,914,228...17,916,918
Ensembl chrNW_004955422:17,914,305...17,917,428

G

guanylyl cyclase domain containing 1

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955455:8,010,187...8,021,666
Ensembl chrNW_004955455:8,007,112...8,021,666

G

hydroxyacid oxidase 1

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955415:17,981,791...18,035,151
Ensembl chrNW_004955415:17,981,791...18,035,224

G

histone deacetylase 1

protein:increased expression:prostate gland

PMID:15042618 PMID:18212746

RGD:2306214 RGD:2306219

NCBI chrNW_004955452:10,636,366...10,668,873
Ensembl chrNW_004955452:10,636,366...10,670,864

G

histone deacetylase 6

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955543:348,314...378,391
Ensembl chrNW_004955543:348,019...378,071

G

homocysteine inducible ER protein with ubiquitin like domain 1

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955433:14,609,275...14,621,774
Ensembl chrNW_004955433:14,608,375...14,621,839

G

hypoxia inducible factor 1 subunit alpha

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955466:8,000,311...8,022,497
Ensembl chrNW_004955466:8,000,044...8,022,497

G

high mobility group box 2

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955403:33,656,314...33,659,115
Ensembl chrNW_004955403:33,656,300...33,659,428

G

high mobility group nucleosome binding domain 5

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955529:1,118,706...1,125,596

G

heme oxygenase 1

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955405:43,124,447...43,128,873
Ensembl chrNW_004955405:43,124,510...43,130,979

G

HNF1 homeobox B

CTD Direct Evidence: marker/mechanism

PMID:18264096 PMID:18758462

NCBI chrNW_004955451:320,283...371,420
Ensembl chrNW_004955451:320,283...371,420

G

heterogeneous nuclear ribonucleoprotein H1

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955408:937,706...944,969
Ensembl chrNW_004955408:936,595...948,064

G

heterogeneous nuclear ribonucleoprotein K

disease_progression

protein:increased expression:prostate gland (mouse)

NCBI chrNW_004955432:3,246,090...3,257,774
Ensembl chrNW_004955432:3,246,092...3,257,774

G

homeobox B13

CTD Direct Evidence: marker/mechanism

PMID:23104005 PMID:24239177 PMID:24390282 PMID:26457646 PMID:32690948 More...

NCBI chrNW_004955451:12,536,415...12,538,169
Ensembl chrNW_004955451:12,536,415...12,538,169

G

homeobox B9

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955451:12,616,465...12,616,926

G

homeobox D3

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955403:20,489,663...20,496,021

G

15-hydroxyprostaglandin dehydrogenase

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955403:32,569,841...32,614,860
Ensembl chrNW_004955403:32,569,841...32,613,763

G

hepsin

CTD Direct Evidence: marker/mechanism

PMID:15583422 PMID:16783571

NCBI chrNW_004955468:4,384,630...4,399,881
Ensembl chrNW_004955468:4,384,630...4,400,379

G

HRas proto-oncogene, GTPase

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955476:11,508,446...11,510,333
Ensembl chrNW_004955476:11,508,126...11,510,333

G

hydroxysteroid 17-beta dehydrogenase 1

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955451:16,449,333...16,452,036
Ensembl chrNW_004955451:16,449,683...16,451,945

G

hydroxysteroid 17-beta dehydrogenase 3

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955422:23,104,752...23,251,250
Ensembl chrNW_004955422:23,101,795...23,148,999

G

hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955435:22,414,605...22,421,682

G

heat shock protein 90 alpha family class B member 1

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955437:9,872,649...9,878,459
Ensembl chrNW_004955437:9,873,908...9,878,459

G

heat shock protein 90 beta family member 1

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955405:38,629,691...38,645,202
Ensembl chrNW_004955405:38,629,691...38,645,202

G

intercellular adhesion molecule 1

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955495:1,561,464...1,573,282
Ensembl chrNW_004955495:1,561,714...1,574,755

G

inhibitor of DNA binding 3, HLH protein

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955452:3,537,352...3,538,921
Ensembl chrNW_004955452:3,537,021...3,560,954

G

isocitrate dehydrogenase (NADP(+)) 1

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955457:6,851,542...6,869,452
Ensembl chrNW_004955457:6,851,517...6,872,367

G

insulin like growth factor 1

CTD Direct Evidence: marker/mechanism
protein:increased expression:prostate gland

PMID:16465378 PMID:19171036 PMID:19208208 PMID:24586243

NCBI chrNW_004955405:37,505,830...37,582,152
Ensembl chrNW_004955405:37,512,201...37,582,152

G

insulin like growth factor 2 receptor

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955439:20,754,915...20,874,759
Ensembl chrNW_004955439:20,752,855...20,851,281

G

insulin like growth factor binding protein 3

CTD Direct Evidence: marker/mechanism|therapeutic

PMID:15318950 PMID:16000583 PMID:24586243

NCBI chrNW_004955456:6,795,560...6,802,147
Ensembl chrNW_004955456:6,795,604...6,800,845

G

insulin like growth factor binding protein 6

CTD Direct Evidence: therapeutic

NCBI chrNW_004955458:377,929...382,109
Ensembl chrNW_004955458:377,929...382,567

G

insulin like growth factor binding protein 7

CTD Direct Evidence: therapeutic

NCBI chrNW_004955447:14,048,834...14,110,264
Ensembl chrNW_004955447:14,047,732...14,108,414

G

immunoglobulin superfamily member 5

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955407:38,468,873...38,510,040

G

interleukin 10

CTD Direct Evidence: marker/mechanism

PMID:16284379 PMID:17999153 PMID:18174250

NCBI chrNW_004955406:42,307,789...42,312,255
Ensembl chrNW_004955406:42,307,664...42,312,779

G

interleukin 16

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955416:11,876,317...11,987,548

G

interleukin 17 receptor C

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955561:1,410,100...1,423,041
Ensembl chrNW_004955561:1,410,941...1,423,023

G

interleukin 17 receptor D

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955430:6,842,756...6,873,195
Ensembl chrNW_004955430:6,848,820...6,898,704

G

interleukin 18

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955412:13,807,361...13,826,007
Ensembl chrNW_004955412:13,806,553...13,825,634

G

interleukin 1 receptor antagonist

CTD Direct Evidence: marker/mechanism

PMID:16106254 PMID:16284379

NCBI chrNW_004955470:1,145,022...1,159,413
Ensembl chrNW_004955470:1,144,810...1,159,471

G

interleukin 2

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955428:18,163,010...18,168,157
Ensembl chrNW_004955428:18,162,467...18,168,265

G

interleukin 24

CTD Direct Evidence: therapeutic

PMID:14678967 PMID:21671747

NCBI chrNW_004955406:42,431,845...42,437,392
Ensembl chrNW_004955406:42,432,795...42,437,016

G

interleukin 27

CTD Direct Evidence: therapeutic

PMID:21801027 PMID:24028178

NCBI chrNW_004955493:6,712,005...6,717,417
Ensembl chrNW_004955493:6,712,005...6,717,417

G

interleukin 6

CTD Direct Evidence: marker/mechanism|therapeutic

PMID:15672864 PMID:17196171 PMID:19011039 PMID:19240160 PMID:25970160

NCBI chrNW_004955410:25,079,835...25,084,390

G

interleukin 6 cytokine family signal transducer

CTD Direct Evidence: marker/mechanism

PMID:29610475 PMID:29662167

NCBI chrNW_004955446:11,790,636...11,837,734
Ensembl chrNW_004955446:11,790,444...11,835,001

G

insulin

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955422:13,909,408...13,910,419
Ensembl chrNW_004955422:13,909,407...13,910,419

G

insulin receptor

protein:increased expression:LNCaP tumors:increased tumor size and INSR levels in human tumor cells injected subcutaneously into mice on a high carbohydrate-high fat diet

NCBI chrNW_004955563:1,867,400...2,011,845
Ensembl chrNW_004955563:1,867,400...2,009,149

G

integrator complex subunit 4

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955414:13,934,830...14,053,648
Ensembl chrNW_004955414:13,934,689...14,056,583

G

interleukin 1 receptor associated kinase 4

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955500:3,010,505...3,039,090
Ensembl chrNW_004955500:3,010,505...3,051,986

G

insulin receptor substrate 1

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955453:7,685,715...7,742,262
Ensembl chrNW_004955453:7,685,715...7,742,262

G

integrin subunit beta 3

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955478:9,788,192...9,830,254
Ensembl chrNW_004955478:9,788,149...9,823,746

G

intersectin 1

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955407:33,056,004...33,275,681
Ensembl chrNW_004955407:33,113,319...33,275,675

G

intersectin 2

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955469:6,358,131...6,493,956
Ensembl chrNW_004955469:6,358,131...6,493,956

G

influenza virus NS1A binding protein

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955406:23,866,705...23,881,184
Ensembl chrNW_004955406:23,866,705...23,881,321

G

jade family PHD finger 2

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955408:5,676,590...5,722,726
Ensembl chrNW_004955408:5,687,544...5,723,122

G

Janus kinase 1

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955423:25,501,989...25,581,826
Ensembl chrNW_004955423:25,524,075...25,580,604

G

Janus kinase 2

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955434:9,227,897...9,341,208
Ensembl chrNW_004955434:9,227,595...9,341,208

G

JAZF zinc finger 1

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955410:29,446,082...29,583,383
Ensembl chrNW_004955410:29,446,090...29,613,100

G

jumonji domain containing 6, arginine demethylase and lysine hydroxylase

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955506:5,577,735...5,588,307
Ensembl chrNW_004955506:5,577,437...5,588,372

G

Jun proto-oncogene, AP-1 transcription factor subunit

disease_progression

Jun interacts with androgen receptor and ETV1 to mediate invasion
protein:increased expression:malignant tissues

NCBI chrNW_004955464:1,107,598...1,110,326

G

junction plakoglobin

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955451:15,993,055...16,004,152
Ensembl chrNW_004955451:15,989,180...16,004,155

G

lysine acetyltransferase 5

protein:increased expression:pancreas, nucleus (human)

NCBI chrNW_004955422:19,557,498...19,565,044
Ensembl chrNW_004955422:19,557,498...19,565,036

G

lysine acetyltransferase 6A

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955536:900,198...1,015,520
Ensembl chrNW_004955536:900,198...1,015,520

G

KDEL endoplasmic reticulum protein retention receptor 1

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955559:2,080,085...2,087,579
Ensembl chrNW_004955559:2,080,085...2,087,579

G

lysine demethylase 6A

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955516:3,151,350...3,346,832
Ensembl chrNW_004955516:3,149,948...3,346,832

G

kelch like ECH associated protein 1

CTD Direct Evidence: marker/mechanism

PMID:24763052 PMID:29610475

NCBI chrNW_004955495:1,704,695...1,711,339
Ensembl chrNW_004955495:1,704,695...1,711,290

G

KLF transcription factor 15

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955421:21,609,709...21,618,920
Ensembl chrNW_004955421:21,609,643...21,620,255

G

KLF transcription factor 6

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955429:1,838,537...1,846,915
Ensembl chrNW_004955429:1,838,537...1,846,915

G

kallikrein related peptidase 5

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955558:1,512,478...1,520,522
Ensembl chrNW_004955558:1,511,818...1,520,613

G

lysine methyltransferase 2A

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955412:19,586,435...19,670,149
Ensembl chrNW_004955412:19,586,141...19,665,527

G

lysine methyltransferase 2C

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955491:6,245,408...6,420,535
Ensembl chrNW_004955491:6,247,249...6,402,470

G

lysine methyltransferase 2D

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955500:7,850,782...7,891,703
Ensembl chrNW_004955500:7,853,292...7,886,067

G

KRAS proto-oncogene, GTPase

CTD Direct Evidence: marker/mechanism

PMID:19117991 PMID:29610475

NCBI chrNW_004955413:20,298,852...20,328,756
Ensembl chrNW_004955413:20,298,824...20,328,758

G

laminin subunit beta 2

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955532:1,115,412...1,127,264
Ensembl chrNW_004955532:1,115,087...1,127,455

G

laminin subunit gamma 1

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955406:21,863,836...21,990,161
Ensembl chrNW_004955406:21,863,836...21,992,199

G

lipid droplet associated hydrolase

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955469:3,161,691...3,277,018
Ensembl chrNW_004955469:3,160,497...3,272,643

G

lactate dehydrogenase B

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955413:17,264,337...17,283,530
Ensembl chrNW_004955413:17,261,118...17,283,593

G

leptin

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955479:9,266,604...9,276,568
Ensembl chrNW_004955479:9,274,516...9,279,472

G

LIF receptor subunit alpha

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955426:23,045,867...23,093,694
Ensembl chrNW_004955426:23,047,167...23,116,891

G

lipopolysaccharide induced TNF factor

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955442:7,054,418...7,084,973
Ensembl chrNW_004955442:7,077,823...7,083,437

G

lemur tyrosine kinase 2

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955460:14,012,047...14,101,969
Ensembl chrNW_004955460:14,012,363...14,098,542

G

beta-defensin 1-like

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955403:53,643,328...53,644,361
Ensembl chrNW_004955403:53,643,300...53,644,505

G

cytochrome P450 1B1

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955441:5,803,397...5,812,131
Ensembl chrNW_004955441:5,803,032...5,812,131

G

cytochrome P450 1A1

CTD Direct Evidence: marker/mechanism

PMID:11275366 PMID:17919073

NCBI chrNW_004955450:3,183,958...3,189,488
Ensembl chrNW_004955450:3,183,750...3,189,488

G

steroid 17-alpha-hydroxylase/17,20 lyase

CTD Direct Evidence: marker/mechanism

PMID:15538743 PMID:16424004 PMID:16859836 PMID:16998812 PMID:17592021

NCBI chrNW_004955485:7,615,132...7,652,899
Ensembl chrNW_004955485:7,645,363...7,650,658

G

25-hydroxycholesterol 7-alpha-hydroxylase

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955444:14,274,818...14,446,068
Ensembl chrNW_004955444:14,275,345...14,444,426

G

aromatase

CTD Direct Evidence: marker/mechanism

PMID:16424004 PMID:17704407

NCBI chrNW_004955409:3,198,622...3,313,072
Ensembl chrNW_004955409:3,266,233...3,313,142

G

cytochrome P450 2E1

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955507:6,293,162...6,303,255
Ensembl chrNW_004955507:6,289,576...6,304,193

G

lysophosphatidic acid receptor 1

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955419:16,190,109...16,324,702
Ensembl chrNW_004955419:16,191,244...16,325,602

G

lipoprotein lipase

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955403:43,646,084...43,672,116
Ensembl chrNW_004955403:43,646,084...43,673,967

G

LDL receptor related protein 1B

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955440:7,048,527...8,475,566
Ensembl chrNW_004955440:7,050,135...8,475,122

G

LDL receptor related protein 2

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955449:5,155,109...5,314,886
Ensembl chrNW_004955449:5,160,946...5,314,948

G

leucine zipper tumor suppressor 1

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955403:43,909,722...43,962,965
Ensembl chrNW_004955403:43,909,681...43,962,971

G

mannose-6-phosphate receptor, cation dependent

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955413:6,144,486...6,156,860
Ensembl chrNW_004955413:6,144,105...6,156,854

G

macrophage immunometabolism regulator

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955418:10,752,250...10,767,791
Ensembl chrNW_004955418:10,752,250...10,767,791

G

mitotic arrest deficient 1 like 1

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955460:9,340,728...9,672,478
Ensembl chrNW_004955460:9,340,681...9,672,134

G

mesencephalic astrocyte derived neurotrophic factor

susceptibility

NCBI chrNW_004955532:3,075,195...3,077,505
Ensembl chrNW_004955532:3,075,110...3,079,116

G

mitogen-activated protein kinase kinase 1

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955450:9,181,851...9,205,277
Ensembl chrNW_004955450:9,181,851...9,239,648

G

mitogen-activated protein kinase kinase 2

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955495:4,695,239...4,718,380
Ensembl chrNW_004955495:4,695,768...4,722,098

G

mitogen-activated protein kinase kinase 3

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955577:1,225,033...1,249,510
Ensembl chrNW_004955577:1,237,287...1,248,541

G

mitogen-activated protein kinase kinase 4

disease_progression

protein:decreased expression:tumor:significant inverse correlation between Gleason pattern and expression (p<0.01)
expression inhibits metastatic colonization of secondary sites by cancer cells in the AT6.1 model system
protein:increased expression:tumor:increased in high-grade prostatic intraepithelial neoplasias and tumor tissues (p<0.0001)

PMID:11306453 PMID:16322247 PMID:17577251

RGD:2293333 RGD:2293334 RGD:2293337

NCBI chrNW_004955467:5,188,036...5,295,570
Ensembl chrNW_004955467:5,187,356...5,307,692

G

mitogen-activated protein kinase kinase 5

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955450:8,207,577...8,458,258
Ensembl chrNW_004955450:8,203,569...8,458,258

G

mitogen-activated protein kinase kinase 6

no_association

protein:increased expression:tumor:increased in high-grade prostatic intraepithelial neoplasias and tumor tissues (p<0.0001)
CTD Direct Evidence: marker/mechanism
expression has no effect on metastatic colonization of secondary sites by cancer cells in the AT6.1 model system

PMID:16322247 PMID:17577251 PMID:32512071

RGD:2293334 RGD:2293337

NCBI chrNW_004955478:3,331,607...3,448,840
Ensembl chrNW_004955478:3,331,607...3,448,842

G

mitogen-activated protein kinase kinase 7

disease_progression

expression inhibits metastatic colonization of secondary sites by cancer cells in the AT6.1 model system
protein:increased expression:tumor:increased in high-grade prostatic intraepithelial neoplasias and tumor tissues (p<0.0001)

PMID:16322247 PMID:17577251

RGD:2293334 RGD:2293337

NCBI chrNW_004955563:1,352,638...1,361,598
Ensembl chrNW_004955563:1,352,638...1,361,598

G

mitogen-activated protein kinase kinase kinase 1

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955446:11,022,091...11,090,136
Ensembl chrNW_004955446:11,021,971...11,090,136

G

mitogen-activated protein kinase kinase kinase 7

no_association

based one the lack of correlation to loss of heterozygosity (LOH)
CTD Direct Evidence: marker/mechanism

PMID:12967473 PMID:17199135

NCBI chrNW_004955411:17,177,335...17,229,957
Ensembl chrNW_004955411:17,177,335...17,229,957

G

mitogen-activated protein kinase 3

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955493:6,870,699...6,876,836
Ensembl chrNW_004955493:6,869,668...6,879,152

G

mitogen-activated protein kinase 9

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955408:391,094...430,638
Ensembl chrNW_004955408:391,094...430,981

G

matrilin 4

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955445:12,027,626...12,040,589
Ensembl chrNW_004955445:12,029,882...12,040,335

G

methyl-CpG binding domain protein 1

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955402:35,320,755...35,334,751
Ensembl chrNW_004955402:35,319,810...35,334,678

G

methyl-CpG binding domain protein 2

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955402:38,761,668...38,829,830
Ensembl chrNW_004955402:38,767,419...38,830,204

G

membrane bound transcription factor peptidase, site 1

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955564:176,230...226,555
Ensembl chrNW_004955564:176,230...228,587

G

melanocortin 2 receptor

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955402:190,513...225,627
Ensembl chrNW_004955402:190,513...225,627

G

MDM2 proto-oncogene

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955458:15,264,028...15,287,290
Ensembl chrNW_004955458:15,263,739...15,286,808

G

mediator complex subunit 12

CTD Direct Evidence: marker/mechanism

PMID:22610119 PMID:29610475

NCBI chrNW_004955475:10,687,168...10,710,286
Ensembl chrNW_004955475:10,687,367...10,710,053

G

MET proto-oncogene, receptor tyrosine kinase

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955432:22,440,671...22,519,592
Ensembl chrNW_004955432:22,440,637...22,517,647

G

MAX dimerization protein MGA

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955416:8,416,236...8,566,371
Ensembl chrNW_004955416:8,471,134...8,563,842

G

macrophage migration inhibitory factor

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955455:8,367,566...8,368,460
Ensembl chrNW_004955455:8,367,566...8,368,460

G

mutL homolog 1

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955421:3,890,291...3,936,892
Ensembl chrNW_004955421:3,890,306...3,936,526

G

membrane metalloendopeptidase

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955448:6,193,113...6,311,666
Ensembl chrNW_004955448:6,226,059...6,314,949

G

matrix metallopeptidase 13

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955412:6,106,994...6,118,760
Ensembl chrNW_004955412:6,106,994...6,118,760

G

matrix metallopeptidase 9

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955445:11,295,500...11,303,322
Ensembl chrNW_004955445:11,295,448...11,303,288

G

myeloperoxidase

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955451:4,743,744...4,753,358
Ensembl chrNW_004955451:4,743,744...4,753,358

G

mutS homolog 3

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955418:29,149,595...29,274,067
Ensembl chrNW_004955418:29,150,085...29,274,437

G

macrophage scavenger receptor 1

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955463:1,197,086...1,263,943
Ensembl chrNW_004955463:1,197,022...1,264,765

G

methylthioadenosine phosphorylase

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955472:12,391,399...12,439,221
Ensembl chrNW_004955472:12,390,032...12,439,206

G

methylenetetrahydrofolate reductase

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955486:2,096,379...2,112,240
Ensembl chrNW_004955486:2,096,379...2,112,240

G

mechanistic target of rapamycin kinase

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955486:2,487,642...2,599,694
Ensembl chrNW_004955486:2,487,642...2,599,694

G

mucin 4, cell surface associated

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955420:12,228,801...12,274,840

G

MAX interactor 1, dimerization protein

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955485:1,088,175...1,156,521
Ensembl chrNW_004955485:1,088,175...1,156,925

G

MYB binding protein 1a

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955467:12,390,371...12,405,055
Ensembl chrNW_004955467:12,390,037...12,404,971

G

MYC proto-oncogene, bHLH transcription factor

CTD Direct Evidence: marker/mechanism

PMID:17173048 PMID:23704919 PMID:29295717 PMID:32512071

NCBI chrNW_004955461:2,714,022...2,718,872
Ensembl chrNW_004955461:2,714,022...2,718,982

G

MYCL proto-oncogene, bHLH transcription factor

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955452:17,390,285...17,397,115
Ensembl chrNW_004955452:17,389,796...17,397,309

G

myosin heavy chain 14

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955559:796,455...856,082
Ensembl chrNW_004955559:797,107...853,053

G

N-acetylglucosamine kinase

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955424:14,205,689...14,215,201
Ensembl chrNW_004955424:14,205,813...14,215,156

G

N-acetyl-alpha-glucosaminidase

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955451:16,445,338...16,449,243
Ensembl chrNW_004955451:16,445,338...16,450,062

G

nibrin

CTD Direct Evidence: marker/mechanism

PMID:14973119 PMID:25415046

NCBI chrNW_004955417:6,840,916...6,880,479
Ensembl chrNW_004955417:6,839,312...6,880,133

G

nuclear receptor coactivator 1

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955469:6,676,780...6,892,587
Ensembl chrNW_004955469:6,794,821...6,892,566

G

nuclear receptor coactivator 2

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955444:9,313,748...9,587,109
Ensembl chrNW_004955444:9,313,447...9,584,913

G

nuclear receptor coactivator 3

CTD Direct Evidence: marker/mechanism

PMID:11927493 PMID:12237244

NCBI chrNW_004955445:10,020,916...10,085,318
Ensembl chrNW_004955445:10,024,308...10,052,472

G

nuclear receptor coactivator 7

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955436:7,110,879...7,238,509
Ensembl chrNW_004955436:7,133,921...7,238,692

G

nuclear receptor corepressor 1

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955467:1,408,292...1,568,539
Ensembl chrNW_004955467:1,409,281...1,546,842

G

N-myc downstream regulated 1

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955461:7,787,068...7,836,380
Ensembl chrNW_004955461:7,786,850...7,836,922

G

N-deacetylase and N-sulfotransferase 2

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955437:18,090,198...18,099,328
Ensembl chrNW_004955437:18,090,198...18,099,328

G

N-deacetylase and N-sulfotransferase 4

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955428:24,376,587...24,636,555
Ensembl chrNW_004955428:24,346,191...24,637,737

G

nectin cell adhesion molecule 2

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955555:1,959,702...1,985,679

G

NFE2 like bZIP transcription factor 2

CTD Direct Evidence: marker/mechanism

PMID:20124447 PMID:23441843

NCBI chrNW_004955403:19,510,122...19,536,428
Ensembl chrNW_004955403:19,532,103...19,535,944

G

nuclear factor I C

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955495:5,095,219...5,139,561
Ensembl chrNW_004955495:5,095,450...5,139,442

G

nerve growth factor receptor

CTD Direct Evidence: marker/mechanism|therapeutic

PMID:17409433 PMID:18056468

NCBI chrNW_004955451:12,030,303...12,047,305
Ensembl chrNW_004955451:12,030,252...12,047,305

G

NIPA like domain containing 3

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955452:4,210,824...4,264,395
Ensembl chrNW_004955452:4,210,824...4,264,951

G

NK3 homeobox 1

CTD Direct Evidence: marker/mechanism

PMID:16817226 PMID:17173048 PMID:17202838 PMID:22610119 PMID:32690948

NCBI chrNW_004955403:46,807,846...46,809,924
Ensembl chrNW_004955403:46,806,178...46,836,310

G

nucleolar protein 8

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955515:5,448,530...5,473,278
Ensembl chrNW_004955515:5,449,578...5,475,147

G

nitric oxide synthase 3

CTD Direct Evidence: marker/mechanism

PMID:12429631 PMID:12445681 PMID:16458450

NCBI chrNW_004955491:5,438,228...5,457,308
Ensembl chrNW_004955491:5,438,010...5,460,814

G

NADPH oxidase 3

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955439:6,764,693...6,820,278
Ensembl chrNW_004955439:6,764,693...6,820,278

G

natriuretic peptide A

CTD Direct Evidence: therapeutic

NCBI chrNW_004955486:2,061,196...2,062,805
Ensembl chrNW_004955486:2,060,735...2,063,003

G

natriuretic peptide receptor 3

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955426:18,491,350...18,559,299
Ensembl chrNW_004955426:18,491,350...18,553,743

G

NAD(P)H quinone dehydrogenase 1

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955484:7,012,373...7,028,182
Ensembl chrNW_004955484:7,012,506...7,027,604

G

nuclear receptor subfamily 3 group C member 1

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955415:10,494,704...10,585,778
Ensembl chrNW_004955415:10,494,640...10,586,221

G

neuropilin 1

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955462:4,101,997...4,241,012
Ensembl chrNW_004955462:4,101,999...4,241,012

G

nucleobindin 2

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955414:32,062,870...32,104,117
Ensembl chrNW_004955414:32,062,835...32,105,975

G

8-oxoguanine DNA glycosylase

CTD Direct Evidence: marker/mechanism

PMID:11956079 PMID:14634453

NCBI chrNW_004955561:1,277,362...1,282,949
Ensembl chrNW_004955561:1,277,365...1,282,793

G

olfactomedin 1

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955733:6,189...30,455
Ensembl chrNW_004955733:6,189...30,455

G

one cut homeobox 2

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955402:41,782,281...41,839,782
Ensembl chrNW_004955402:41,782,281...41,839,782

G

prolyl 4-hydroxylase subunit beta

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955506:1,307,932...1,322,011
Ensembl chrNW_004955506:1,307,932...1,324,027

G

p21 (RAC1) activated kinase 6

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955416:7,190,584...7,211,705
Ensembl chrNW_004955416:7,178,524...7,212,053

G

partner and localizer of BRCA2

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955493:2,149,053...2,175,482
Ensembl chrNW_004955493:2,147,862...2,175,781

G

progestin and adipoQ receptor family member 4

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955442:14,373,092...14,375,862
Ensembl chrNW_004955442:14,373,092...14,375,862

G

par-3 family cell polarity regulator

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955462:2,930,171...3,457,358
Ensembl chrNW_004955462:2,849,181...3,457,478

G

poly(ADP-ribose) polymerase 1

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955489:520,875...557,609
Ensembl chrNW_004955489:520,875...557,615

G

PATJ crumbs cell polarity complex component

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955423:27,408,334...27,637,065
Ensembl chrNW_004955423:27,409,623...27,629,731

G

pro-apoptotic WT1 regulator

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955405:18,434,711...18,540,710
Ensembl chrNW_004955405:18,434,711...18,540,710

G

paired box 6

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955476:10,058,979...10,074,668
Ensembl chrNW_004955476:10,058,961...10,074,162

G

protocadherin 8

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955404:50,403,752...50,413,264

G

phosphodiesterase 4D

CTD Direct Evidence: marker/mechanism

PMID:16740699 PMID:29662167

NCBI chrNW_004955446:7,914,326...9,252,527
Ensembl chrNW_004955446:8,211,877...9,252,653

G

pyruvate dehydrogenase E1 subunit alpha 1

CTD Direct Evidence: marker/mechanism

PMID:17013881 PMID:29335542

NCBI chrNW_004955586:98,492...114,927
Ensembl chrNW_004955586:97,172...114,928

G

protein disulfide isomerase family A member 3

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955416:10,197,957...10,221,104
Ensembl chrNW_004955416:10,198,099...10,220,792

G

pyruvate dehydrogenase phosphatase catalytic subunit 1

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955417:10,219,096...10,227,483
Ensembl chrNW_004955417:10,219,595...10,228,669

G

PDS5 cohesin associated factor A

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955443:7,475,434...7,603,548
Ensembl chrNW_004955443:7,475,385...7,604,714

G

PDZ domain containing 1

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955568:405,697...436,346
Ensembl chrNW_004955568:386,904...436,346

G

PDZK1 interacting protein 1

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955464:11,339,800...11,344,492
Ensembl chrNW_004955464:11,339,800...11,344,492

G

proenkephalin

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955454:15,425,712...15,426,685
Ensembl chrNW_004955454:15,426,017...15,426,685

G

phosphoglycerate mutase 2

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955456:7,909,891...7,912,116
Ensembl chrNW_004955456:7,909,891...7,912,116

G

progesterone receptor membrane component 1

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955534:698,895...706,586
Ensembl chrNW_004955534:698,734...706,946

G

prohibitin 1

mRNA, protein:increased expression:prostate gland

NCBI chrNW_004955451:12,110,290...12,119,870
Ensembl chrNW_004955451:12,110,290...12,120,124

G

phosphoglycerate dehydrogenase

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955435:22,757,473...22,803,123
Ensembl chrNW_004955435:22,757,454...22,803,123

G

phosphatidylinositol glycan anchor biosynthesis class P

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955407:36,178,323...36,185,317

G

phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha

CTD Direct Evidence: marker/mechanism

PMID:17013881 PMID:29610475

NCBI chrNW_004955420:8,355,415...8,427,024
Ensembl chrNW_004955420:8,356,353...8,427,024

G

phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955501:251,829...381,255
Ensembl chrNW_004955501:259,645...379,909

G

phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955486:3,813,923...3,837,563
Ensembl chrNW_004955486:3,813,923...3,838,119

G

phosphoinositide-3-kinase regulatory subunit 1

CTD Direct Evidence: marker/mechanism

PMID:29610475 PMID:29662167 PMID:33129824

NCBI chrNW_004955446:1,020,707...1,098,327
Ensembl chrNW_004955446:1,020,043...1,098,820

G

phosphoinositide-3-kinase regulatory subunit 2

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955524:3,234,111...3,241,445
Ensembl chrNW_004955524:3,234,111...3,241,173

G

paired like homeodomain 3

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955485:8,130,244...8,140,292
Ensembl chrNW_004955485:8,130,244...8,140,292

G

plakophilin 3

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955476:11,611,240...11,619,210
Ensembl chrNW_004955476:11,611,240...11,619,780

G

plasminogen activator, urokinase

CTD Direct Evidence: marker/mechanism

PMID:11454671 PMID:16430655 PMID:17192053

NCBI chrNW_004955437:17,995,726...18,000,542
Ensembl chrNW_004955437:17,994,537...18,000,209

G

plasminogen activator, urokinase receptor

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955555:1,378,505...1,393,395
Ensembl chrNW_004955555:1,378,793...1,393,324

G

pleckstrin 2

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955466:2,818,004...2,836,688
Ensembl chrNW_004955466:2,817,939...2,836,688

G

PML nuclear body scaffold

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955450:3,654,854...3,692,057
Ensembl chrNW_004955450:3,656,498...3,692,406

G

PMS1 homolog 1, mismatch repair system component

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955403:9,021,488...9,100,442
Ensembl chrNW_004955403:9,022,078...9,100,442

G

podocalyxin like

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955410:36,191,797...36,239,970

G

DNA polymerase kappa

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955425:25,164,749...25,228,064
Ensembl chrNW_004955425:25,161,222...25,228,524

G

paraoxonase 1

CTD Direct Evidence: marker/mechanism

PMID:12783936 PMID:15538743 PMID:21716162

NCBI chrNW_004955432:11,893,473...11,923,035
Ensembl chrNW_004955432:11,893,473...11,923,339

G

peroxisome proliferator activated receptor alpha

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955413:30,306,563...30,366,245
Ensembl chrNW_004955413:30,307,219...30,359,500

G

PPFIA binding protein 2

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955414:23,269,050...23,418,804
Ensembl chrNW_004955414:23,270,072...23,419,523

G

periplakin

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955442:12,581,918...12,627,407
Ensembl chrNW_004955442:12,581,879...12,626,516

G

protein phosphatase 2 regulatory subunit Balpha

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955403:49,042,188...49,113,743
Ensembl chrNW_004955403:49,042,185...49,113,737

G

protein phosphatase 3 catalytic subunit alpha

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955496:6,934,542...7,059,745
Ensembl chrNW_004955496:6,908,224...7,059,816

G

peroxiredoxin 2

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955415:31,880,801...31,884,453
Ensembl chrNW_004955415:31,880,588...31,884,778

G

protein kinase cAMP-activated catalytic subunit beta

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955423:9,630,308...9,747,820
Ensembl chrNW_004955423:9,629,378...9,747,820

G

protein kinase C zeta

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955486:8,947,579...9,021,702
Ensembl chrNW_004955486:8,947,579...9,021,702

G

protein kinase, DNA-activated, catalytic subunit

CTD Direct Evidence: marker/mechanism

PMID:17196815 PMID:25415046

NCBI chrNW_004955454:7,733,697...7,890,896
Ensembl chrNW_004955454:7,733,978...7,890,867

G

prion protein (Kanno blood group)

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955415:15,442,313...15,454,644
Ensembl chrNW_004955415:15,442,313...15,454,644

G

paired related homeobox 1

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955462:6,919,905...6,991,733
Ensembl chrNW_004955462:6,919,899...6,991,733

G

serine protease 8

disease_progression

mRNA:increased expression:blood
mRNA:increased expression:prostate gland
CTD Direct Evidence: marker/mechanism

PMID:11173941 PMID:12518323 PMID:16541421

RGD:2292484 RGD:2292487

NCBI chrNW_004955493:7,970,929...7,976,885
Ensembl chrNW_004955493:7,971,609...7,976,666

G

prostate stem cell antigen

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955454:1,425,255...1,429,786
Ensembl chrNW_004955454:1,425,255...1,429,786

G

PSMC3 interacting protein

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955451:16,464,233...16,467,896
Ensembl chrNW_004955451:16,464,233...16,467,896

G

phosphatase and tensin homolog

disease_progression

CTD Direct Evidence: marker/mechanism

PMID:9371490 PMID:11175795 PMID:11854455 PMID:16421604 PMID:17173048 More...

RGD:1302553 RGD:2292497 RGD:2292510

NCBI chrNW_004955425:5,007,811...5,091,829
Ensembl chrNW_004955425:5,014,147...5,091,829

G

prostaglandin-endoperoxide synthase 2

severity

CTD Direct Evidence: marker/mechanism
protein:altered localization
DNA:hypermethylation

PMID:10753955 PMID:14754878 PMID:15126378 PMID:16506214 PMID:17609663 More...

RGD:2300123 RGD:2300193

NCBI chrNW_004955406:25,077,988...25,086,259
Ensembl chrNW_004955406:25,079,945...25,086,171

G

parathyroid hormone like hormone

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955505:6,834,533...6,846,909
Ensembl chrNW_004955505:6,834,533...6,847,335

G

protein tyrosine phosphatase receptor type C

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955406:35,005,577...35,127,395
Ensembl chrNW_004955406:35,005,214...35,129,552

G

protein tyrosine phosphatase receptor type K

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955436:8,975,742...9,371,608
Ensembl chrNW_004955436:8,975,554...9,380,971

G

peptidyl-tRNA hydrolase 2

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955451:3,370,761...3,375,979
Ensembl chrNW_004955451:3,370,761...3,375,979

G

glutaminyl-tRNA synthetase 1

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955532:1,093,444...1,100,591
Ensembl chrNW_004955532:1,092,125...1,100,603

G

RAB4B, member RAS oncogene family

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955578:559,029...568,966
Ensembl chrNW_004955578:559,029...568,966

G

RAD23 homolog B, nucleotide excision repair protein

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955419:19,428,415...19,473,181
Ensembl chrNW_004955419:19,429,970...19,460,796

G

Raf-1 proto-oncogene, serine/threonine kinase

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955429:17,980,956...18,049,723
Ensembl chrNW_004955429:18,025,932...18,049,723

G

recombination activating 1

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955422:9,891,878...9,928,569
Ensembl chrNW_004955422:9,891,878...9,919,504

G

ralA binding protein 1

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955402:2,571,672...2,616,040
Ensembl chrNW_004955402:2,569,637...2,616,040

G

ras related dexamethasone induced 1

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955577:452,993...454,659
Ensembl chrNW_004955577:452,993...454,713

G

RB transcriptional corepressor 1

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955431:1,960,765...2,124,576
Ensembl chrNW_004955431:1,960,661...2,124,576

G

REC8 meiotic recombination protein

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955409:36,223,783...36,231,749
Ensembl chrNW_004955409:36,223,844...36,230,948

G

RELA proto-oncogene, NF-kB subunit

disease_progression

protein:altered localization, increased expression:nucleus, prostate gland

NCBI chrNW_004955422:19,602,930...19,612,263
Ensembl chrNW_004955422:19,603,345...19,611,516

G

riboflavin kinase

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955512:2,889,265...2,898,195
Ensembl chrNW_004955512:2,890,106...2,898,195

G

regulatory factor X6

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955436:213,810...278,699
Ensembl chrNW_004955436:213,809...280,577

G

repulsive guidance molecule BMP co-receptor b

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955418:14,305,634...14,321,804
Ensembl chrNW_004955418:14,308,392...14,326,762

G

ring finger protein, LIM domain interacting

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955562:508,723...531,699
Ensembl chrNW_004955562:510,739...531,830

G

ribonuclease L

CTD Direct Evidence: marker/mechanism

PMID:16114055 PMID:17020975 PMID:27318894

NCBI chrNW_004955406:21,413,950...21,424,860
Ensembl chrNW_004955406:21,411,980...21,425,052

G

ring finger protein 130

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955408:561,719...660,775
Ensembl chrNW_004955408:599,478...661,903

G

ring finger protein 31

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955409:36,240,008...36,252,166
Ensembl chrNW_004955409:36,240,008...36,252,166

G

ring finger protein 43

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955451:4,604,985...4,680,762
Ensembl chrNW_004955451:4,604,985...4,680,762

G

roundabout guidance receptor 1

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955407:12,593,911...13,485,723
Ensembl chrNW_004955407:13,107,235...13,487,053

G

roundabout guidance receptor 2

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955407:14,301,689...15,549,561
Ensembl chrNW_004955407:14,305,498...14,842,790

G

ribosomal protein L10

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955580:903,618...906,439
Ensembl chrNW_004955580:903,412...906,439

G

ribosomal protein L11

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955452:3,626,609...3,630,911
Ensembl chrNW_004955452:3,626,609...3,633,209

G

ribosomal protein L12

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955419:1,154,397...1,157,508
Ensembl chrNW_004955419:1,154,397...1,157,500

G

ribophorin II

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955422:24,497,288...24,550,439
Ensembl chrNW_004955422:24,497,228...24,550,439

G

regulation of nuclear pre-mRNA domain containing 2

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955413:321,707...420,626
Ensembl chrNW_004955413:324,873...419,347

G

ribosomal protein S19

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955555:969,345...976,122
Ensembl chrNW_004955555:969,340...976,509

G

RAS related

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955559:1,244,658...1,248,774
Ensembl chrNW_004955559:1,244,658...1,248,774

G

retinoid X receptor alpha

protein:decreased expression:prostate
CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955513:3,313,544...3,386,544
Ensembl chrNW_004955513:3,335,897...3,386,994

G

sterile alpha motif domain containing 9

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955432:9,957,521...9,972,622
Ensembl chrNW_004955432:9,957,677...9,962,389

G

stromal cell derived factor 2 like 1

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955442:17,468,302...17,470,296
Ensembl chrNW_004955442:17,468,302...17,470,296

G

selenoprotein P

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955426:26,951,003...26,961,839

G

selenoprotein S

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955416:28,152,984...28,162,173
Ensembl chrNW_004955416:28,153,460...28,162,095

G

SUMO specific peptidase 6

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955502:4,082,217...4,180,696
Ensembl chrNW_004955502:4,082,215...4,181,966

G

serine incorporator 3

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955445:12,837,616...12,868,631
Ensembl chrNW_004955445:12,837,586...12,865,758

G

serpin family A member 3

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955438:17,758,763...17,766,113
Ensembl chrNW_004955438:17,758,718...17,766,180

G

serpin family E member 1

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955456:16,147,523...16,157,040
Ensembl chrNW_004955456:16,145,944...16,157,142

G

serpin family F member 1

treatment

CTD Direct Evidence: therapeutic
human gene in a rat model

PMID:20360944 PMID:21671747

NCBI chrNW_004955481:1,414,930...1,426,436
Ensembl chrNW_004955481:1,414,930...1,426,241

G

sestrin 3

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955412:100,335...125,395
Ensembl chrNW_004955412:107,861...125,944

G

SET domain containing 2, histone lysine methyltransferase

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955420:25,070,626...25,178,410
Ensembl chrNW_004955420:25,090,798...25,177,760

G

SET domain bifurcated histone lysine methyltransferase 1

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955588:290,497...338,438
Ensembl chrNW_004955588:290,168...338,426

G

splicing factor 3b subunit 1

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955403:3,134,960...3,163,395
Ensembl chrNW_004955403:3,134,955...3,166,121

G

sex hormone binding globulin

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955467:9,301,173...9,305,010

G

SIL1 nucleotide exchange factor

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955418:1,322,644...1,583,352
Ensembl chrNW_004955418:1,392,985...1,583,376

G

sirtuin 1

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955425:20,280,725...20,307,663
Ensembl chrNW_004955425:20,279,963...20,307,663

G

solute carrier family 12 member 2

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955415:1,138,297...1,219,241
Ensembl chrNW_004955415:1,137,327...1,219,241

G

solute carrier family 22 member 3

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955439:20,367,324...20,476,891
Ensembl chrNW_004955439:20,367,333...20,476,891

G

solute carrier family 26 member 4

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955410:12,008,067...12,057,147
Ensembl chrNW_004955410:12,009,102...12,059,637

G

solute carrier family 30 member 4

disease_progression

protein:decreased expression:prostate gland

NCBI chrNW_004955409:7,963,454...7,991,600
Ensembl chrNW_004955409:7,963,454...7,995,027

G

solute carrier family 31 member 1

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955419:14,221,258...14,264,288
Ensembl chrNW_004955419:14,220,495...14,264,699

G

solute carrier family 39 member 1

CTD Direct Evidence: marker/mechanism

PMID:16700911 PMID:19208208

NCBI chrNW_004955545:556,210...559,732
Ensembl chrNW_004955545:554,947...560,336

G

solute carrier family 4 member 2

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955491:5,498,472...5,513,389
Ensembl chrNW_004955491:5,499,033...5,517,319

G

solute carrier family 5 member 5

CTD Direct Evidence: therapeutic

PMID:12489024 PMID:14633711

NCBI chrNW_004955524:3,372,539...3,380,758

G

solute carrier family 7 member 1

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955431:16,270,648...16,315,280
Ensembl chrNW_004955431:16,260,605...16,315,332

G

SMAD family member 4

disease_progression

NCBI chrNW_004955402:35,956,080...36,001,746
Ensembl chrNW_004955402:35,961,165...35,994,538

G

SNF2 related chromatin remodeling ATPase 1

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955473:5,498,738...5,572,863
Ensembl chrNW_004955473:5,498,674...5,573,169

G

superoxide dismutase 2

CTD Direct Evidence: marker/mechanism|therapeutic

PMID:12592389 PMID:15512801 PMID:17465268 PMID:17646272 PMID:18829485 More...

NCBI chrNW_004955439:21,209,101...21,223,538
Ensembl chrNW_004955439:21,209,101...21,224,163

G

SRY-box transcription factor 2

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955420:10,671,888...10,674,080
Ensembl chrNW_004955420:10,671,978...10,672,934

G

Sp5 transcription factor

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955449:4,076,872...4,079,887
Ensembl chrNW_004955449:4,076,530...4,080,169

G

spermatogenesis associated 18

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955447:18,401,881...18,437,878

G

spen family transcriptional repressor

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955527:2,279,438...2,343,263
Ensembl chrNW_004955527:2,280,459...2,343,262

G

serine peptidase inhibitor Kazal type 1

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955415:6,328,672...6,378,611
Ensembl chrNW_004955415:6,371,059...6,378,529

G

serine peptidase inhibitor Kazal type 5

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955415:6,118,616...6,186,632

G

SPARC (osteonectin), cwcv and kazal like domains proteoglycan 1

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955408:31,954,622...32,465,463
Ensembl chrNW_004955408:31,957,882...32,465,461

G

spondin 2

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955514:598,840...603,390
Ensembl chrNW_004955514:596,829...604,051

G

speckle type BTB/POZ protein

CTD Direct Evidence: marker/mechanism

PMID:22610119 PMID:29295717 PMID:29610475

NCBI chrNW_004955451:11,897,642...11,970,269
Ensembl chrNW_004955451:11,897,592...11,970,269

G

secreted phosphoprotein 1

NCBI chrNW_004955474:1,914,477...1,922,025
Ensembl chrNW_004955474:1,913,829...1,922,016

G

steroid 5 alpha-reductase 1

CTD Direct Evidence: marker/mechanism

PMID:17707058 PMID:18500220 PMID:20564326

NCBI chrNW_004955504:4,360,909...4,388,964
Ensembl chrNW_004955504:4,360,453...4,391,133

G

steroid 5 alpha-reductase 2

CTD Direct Evidence: marker/mechanism

PMID:16998812 PMID:17136762 PMID:17823934 PMID:18306354 PMID:18500220

NCBI chrNW_004955441:12,149...95,733
Ensembl chrNW_004955441:10,443...95,743

G

single stranded DNA binding protein 2

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955418:28,562,735...28,813,541
Ensembl chrNW_004955418:28,633,753...28,808,117

G

signal sequence receptor subunit 2

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955545:2,205,906...2,213,780
Ensembl chrNW_004955545:2,205,906...2,212,851

G

ST14 transmembrane serine protease matriptase

protein:increased expression:prostate gland
CTD Direct Evidence: marker/mechanism

PMID:17013881 PMID:18813126

NCBI chrNW_004955412:31,091,313...31,129,050
Ensembl chrNW_004955412:31,090,504...31,129,050

G

stabilin 2

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955405:38,393,636...38,533,701
Ensembl chrNW_004955405:38,393,650...38,533,815

G

StAR related lipid transfer domain containing 10

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955414:18,641,346...18,664,886
Ensembl chrNW_004955414:18,641,346...18,666,381

G

StAR related lipid transfer domain containing 3

CTD Direct Evidence: marker/mechanism

PMID:17013881 PMID:17592021

NCBI chrNW_004955451:14,395,088...14,412,041
Ensembl chrNW_004955451:14,394,466...14,413,810

G

signal transducer and activator of transcription 3

CTD Direct Evidence: marker/mechanism
protein:increased expression:prostate gland

PMID:14975756 PMID:16427044 PMID:18317887 PMID:25970160

NCBI chrNW_004955451:16,320,326...16,348,505
Ensembl chrNW_004955451:16,319,904...16,357,687

G

signal transducer and activator of transcription 5B

NCBI chrNW_004955451:16,253,645...16,295,337
Ensembl chrNW_004955451:16,255,398...16,272,214

G

STEAP4 metalloreductase

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955432:5,618,086...5,641,372
Ensembl chrNW_004955432:5,618,086...5,641,565

G

stathmin 1

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955452:5,387,696...5,393,337
Ensembl chrNW_004955452:5,388,150...5,391,518

G

sulfotransferase family 2B member 1

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955559:1,942,878...1,968,895

G

surfeit 4

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955513:2,715,638...2,719,537
Ensembl chrNW_004955513:2,714,321...2,720,073

G

transporter 1, ATP binding cassette subfamily B member

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955437:1,504,549...1,511,110
Ensembl chrNW_004955437:1,504,947...1,511,097

G

TBC1 domain family member 2

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955419:27,266,214...27,312,908
Ensembl chrNW_004955419:27,266,207...27,312,839

G

TBL1X/Y related 1

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955420:6,546,529...6,705,481
Ensembl chrNW_004955420:6,546,529...6,705,487

G

T-box transcription factor 3

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955455:15,988,153...16,000,156
Ensembl chrNW_004955455:15,988,663...16,000,063

G

thromboxane A synthase 1

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955494:3,161,032...3,321,974
Ensembl chrNW_004955494:3,160,653...3,334,411

G

transcription elongation factor A like 7

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955548:467,664...470,196

G

transcobalamin 2

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955455:4,827,030...4,849,810
Ensembl chrNW_004955455:4,826,694...4,849,613

G

t-complex 1

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955439:21,114,038...21,124,379

G

telomerase reverse transcriptase

CTD Direct Evidence: marker/mechanism

PMID:19151717 PMID:21743467

NCBI chrNW_004955504:649,248...669,796
Ensembl chrNW_004955504:651,779...670,589

G

tet methylcytosine dioxygenase 2

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955496:3,885,684...3,963,056
Ensembl chrNW_004955496:3,885,035...3,926,106

G

transforming growth factor alpha

CTD Direct Evidence: therapeutic

NCBI chrNW_004955424:14,616,390...14,709,723
Ensembl chrNW_004955424:14,616,259...14,710,183

G

transforming growth factor beta 1

CTD Direct Evidence: marker/mechanism

PMID:15159307 PMID:18082198

NCBI chrNW_004955555:274,405...288,441
Ensembl chrNW_004955555:270,652...288,441

G

transforming growth factor beta receptor 2

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955430:21,919,338...21,999,688
Ensembl chrNW_004955430:21,932,553...22,001,837

G

thymocyte nuclear protein 1

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955412:35,061,874...35,067,631
Ensembl chrNW_004955412:35,061,874...35,067,352

G

TIMP metallopeptidase inhibitor 4

CTD Direct Evidence: marker/mechanism

PMID:16940965 PMID:17013881

NCBI chrNW_004955429:14,689,016...14,693,211
Ensembl chrNW_004955429:14,685,031...14,693,211

G

TIR domain containing adaptor protein

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955412:27,303,548...27,315,031
Ensembl chrNW_004955412:27,312,489...27,315,031

G

tight junction protein 3

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955495:5,620,817...5,647,211
Ensembl chrNW_004955495:5,630,066...5,647,090

G

toll like receptor 4

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955419:10,190,937...10,201,896
Ensembl chrNW_004955419:10,191,120...10,202,135

G

toll like receptor 5

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955520:1,544,840...1,562,081
Ensembl chrNW_004955520:1,556,523...1,559,093

G

toll like receptor 6

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955443:8,401,461...8,427,175
Ensembl chrNW_004955443:8,422,534...8,424,942

G

transmembrane protein with EGF like and two follistatin like domains 2

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955403:7,122,019...7,353,769
Ensembl chrNW_004955403:7,121,834...7,354,908

G

TATA element modulatory factor 1

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955421:18,810,199...18,837,767
Ensembl chrNW_004955421:18,810,199...18,837,761

G

tropomodulin 1

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955419:27,841,424...27,915,540
Ensembl chrNW_004955419:27,841,424...27,915,540

G

thymosin beta 4 X-linked

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955544:266,397...268,447
Ensembl chrNW_004955544:266,397...268,447

G

TNF receptor superfamily member 11a

protein:increased expression:prostate gland

NCBI chrNW_004955402:46,242,329...46,298,157
Ensembl chrNW_004955402:46,264,164...46,296,368

G

TNF receptor superfamily member 21

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955437:11,877,051...11,915,220
Ensembl chrNW_004955437:11,876,895...11,915,460

G

TNF superfamily member 10

CTD Direct Evidence: therapeutic

PMID:16368536 PMID:17636462 PMID:17718901 PMID:21209944

NCBI chrNW_004955420:2,550,392...2,566,448
Ensembl chrNW_004955420:2,549,142...2,566,564

G

target of myb1 like 1 membrane trafficking protein

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955451:7,642,679...7,690,957
Ensembl chrNW_004955451:7,639,509...7,690,957

G

DNA topoisomerase II alpha

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955451:14,928,273...14,964,855
Ensembl chrNW_004955451:14,929,136...14,964,723

G

tumor protein p53

CTD Direct Evidence: marker/mechanism

PMID:16434975 PMID:17202838 PMID:20875869 PMID:21946351 PMID:25735316 More...

NCBI chrNW_004955467:9,241,391...9,256,716
Ensembl chrNW_004955467:9,252,130...9,255,928

G

tumor protein p63

protein:decreased expression:prostate gland
CTD Direct Evidence: marker/mechanism
mRNA:decreased expression:prostate gland

PMID:17189982 PMID:17982114 PMID:22581815

RGD:2315433 RGD:2315434

NCBI chrNW_004955420:18,178,639...18,384,786
Ensembl chrNW_004955420:18,176,155...18,384,786

G

trophoblast glycoprotein

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955411:10,203,144...10,206,711

G

tumor protein D52

CTD Direct Evidence: marker/mechanism|therapeutic

PMID:17875733 PMID:27415467

NCBI chrNW_004955444:1,230,730...1,261,839
Ensembl chrNW_004955444:1,230,730...1,264,526

G

TPD52 like 1

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955436:6,648,140...6,672,474
Ensembl chrNW_004955436:6,602,051...6,671,978

G

tripeptidyl peptidase 1

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955414:22,324,847...22,330,912
Ensembl chrNW_004955414:22,324,856...22,330,912

G

TNF receptor associated factor 1

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955419:7,117,869...7,145,274
Ensembl chrNW_004955419:7,121,382...7,137,763

G

transient receptor potential cation channel subfamily M member 4

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955559:1,539,036...1,581,800
Ensembl chrNW_004955559:1,546,365...1,581,712

G

thiosulfate sulfurtransferase

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955413:23,528,468...23,534,890
Ensembl chrNW_004955413:23,528,417...23,534,979

G

tetratricopeptide repeat domain 9C

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955599:481,717...488,678
Ensembl chrNW_004955599:482,240...488,045

G

thioredoxin domain containing 5

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955465:6,034,006...6,053,779
Ensembl chrNW_004955465:6,033,968...6,053,769

G

thioredoxin reductase 2

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955442:18,150,060...18,205,775
Ensembl chrNW_004955442:18,152,152...18,204,327

G

thymidylate synthetase

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955402:9,295,862...9,304,952
Ensembl chrNW_004955402:9,296,321...9,306,631

G

U2 small nuclear RNA auxiliary factor 1

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955407:38,895,741...38,909,820
Ensembl chrNW_004955407:38,895,711...38,909,820

G

uridine-cytidine kinase 2

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955462:10,815,496...10,925,364
Ensembl chrNW_004955462:10,815,389...10,886,227

G

uncoupling protein 3

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955414:17,558,889...17,578,108
Ensembl chrNW_004955414:17,558,889...17,578,737

G

uridine monophosphate synthetase

CTD Direct Evidence: marker/mechanism

PMID:15999119 PMID:19082440

NCBI chrNW_004955427:23,825,529...23,841,427
Ensembl chrNW_004955427:23,825,523...23,841,152

G

unc-13 homolog D

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955506:6,407,073...6,423,406
Ensembl chrNW_004955506:6,407,723...6,423,406

G

USO1 vesicle transport factor

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955474:1,647,670...1,704,869
Ensembl chrNW_004955474:1,647,361...1,705,548

G

ubiquitin specific peptidase 28

CTD Direct Evidence: marker/mechanism

PMID:29610475 PMID:29662167

NCBI chrNW_004955412:15,425,136...15,469,819
Ensembl chrNW_004955412:15,426,159...15,443,023

G

ubiquitin specific peptidase 7

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955442:9,316,022...9,355,751
Ensembl chrNW_004955442:9,315,225...9,356,393

G

ubiquitously expressed prefoldin like chaperone

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955516:421,402...429,804
Ensembl chrNW_004955516:420,616...430,134

G

vav guanine nucleotide exchange factor 3

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955435:11,326,910...11,599,043
Ensembl chrNW_004955435:11,326,910...11,599,043

G

valosin containing protein

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955472:1,111,649...1,124,076
Ensembl chrNW_004955472:1,107,164...1,124,076

G

vitamin D receptor

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955500:6,745,725...6,798,052
Ensembl chrNW_004955500:6,745,678...6,798,048

G

vascular endothelial growth factor A

CTD Direct Evidence: marker/mechanism

PMID:12893367 PMID:16606632 PMID:16908180 PMID:20052738

NCBI chrNW_004955437:9,527,445...9,541,908

G

vimentin

CTD Direct Evidence: marker/mechanism

PMID:17566973 PMID:24763052

NCBI chrNW_004955429:10,708,852...10,716,743
Ensembl chrNW_004955429:10,707,719...10,717,554

G

vasoactive intestinal peptide

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955439:9,021,923...9,031,783
Ensembl chrNW_004955439:9,021,904...9,031,792

G

VPS52 subunit of GARP complex

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955437:1,820,355...1,833,615
Ensembl chrNW_004955437:1,820,817...1,833,363

G

WW domain containing adaptor with coiled-coil

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955462:2,358,842...2,435,644
Ensembl chrNW_004955462:2,358,842...2,435,628

G

WASP family member 3

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955497:6,100,633...6,190,639
Ensembl chrNW_004955497:6,102,909...6,190,770

G

Wnt family member 10B

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955500:7,782,782...7,800,281
Ensembl chrNW_004955500:7,782,782...7,788,309

G

Wnt family member 11

disease_progression

mRNA:increased expression:tumor:increased expression in 4/4 cases with Gleason sum score >= 7, also in progression from androgen-dependence to androgen-independence in xenografts

NCBI chrNW_004955414:15,674,478...15,694,758
Ensembl chrNW_004955414:15,674,940...15,694,883

G

Wnt family member 4

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955452:2,319,446...2,344,740
Ensembl chrNW_004955452:2,319,446...2,344,989

G

X-linked inhibitor of apoptosis

severity

NCBI chrNW_004955473:10,823,795...10,878,256
Ensembl chrNW_004955473:10,827,435...10,840,604

G

exportin 1

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955424:22,370,006...22,420,568
Ensembl chrNW_004955424:22,370,006...22,420,568

G

X-ray repair cross complementing 1

CTD Direct Evidence: marker/mechanism

PMID:16406883 PMID:17196815 PMID:17486273

NCBI chrNW_004955555:1,293,416...1,315,839
Ensembl chrNW_004955555:1,293,416...1,315,839

G

zinc finger BED-type containing 1

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955499:1,484,850...1,487,143

G

zinc finger and BTB domain containing 16

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955412:15,668,332...15,845,384
Ensembl chrNW_004955412:15,668,332...15,845,372

G

zinc finger and BTB domain containing 20

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955427:14,409,700...15,231,495
Ensembl chrNW_004955427:14,409,700...14,453,926

G

zinc finger and BTB domain containing 7A

CTD Direct Evidence: therapeutic

NCBI chrNW_004955495:4,747,905...4,754,066
Ensembl chrNW_004955495:4,740,901...4,753,992

G

zinc finger AN1-type containing 5

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955434:841,410...847,598
Ensembl chrNW_004955434:841,409...847,598

G

zinc finger homeobox 3

CTD Direct Evidence: marker/mechanism

PMID:16637072 PMID:17013881 PMID:29610475

NCBI chrNW_004955484:5,470,203...5,746,325
Ensembl chrNW_004955484:5,474,769...5,789,707

G

ZFP36 ring finger protein like 2

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955441:10,467,608...10,469,885

G

Zic family member 2

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955404:10,731,987...10,735,599

G

zinc finger MYM-type containing 3

CTD Direct Evidence: marker/mechanism

PMID:24763052 PMID:29610475 PMID:29662167

NCBI chrNW_004955475:10,801,637...10,818,123
Ensembl chrNW_004955475:10,801,255...10,818,375

G

zinc finger protein 292

CTD Direct Evidence: marker/mechanism

PMID:29610475 PMID:29662167

NCBI chrNW_004955411:14,182,059...14,263,109
Ensembl chrNW_004955411:14,182,059...14,263,109

castration-resistant prostate carcinoma

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

androgen receptor

CTD Direct Evidence: marker/mechanism

PMID:18985049 PMID:24740322 PMID:28500234 PMID:28757136

NCBI chrNW_004955475:7,013,960...7,192,473
Ensembl chrNW_004955475:7,013,960...7,186,069

G

anti-silencing function 1B histone chaperone

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955415:32,818,592...32,828,651
Ensembl chrNW_004955415:32,817,547...32,828,651

G

cyclin E2

treatment

NCBI chrNW_004955417:11,027,749...11,039,945
Ensembl chrNW_004955417:11,027,749...11,040,017

G

CD46 molecule

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955406:43,002,817...43,034,555

G

centromere protein K

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955446:3,531,702...3,583,914
Ensembl chrNW_004955446:3,531,702...3,583,914

G

chromodomain helicase DNA binding protein 1

DNA:mutations: :

NCBI chrNW_004955418:14,200,618...14,268,361
Ensembl chrNW_004955418:14,200,617...14,268,361

G

lysine demethylase 1A

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955452:3,044,042...3,104,650
Ensembl chrNW_004955452:3,044,264...3,104,418

G

NUF2 component of NDC80 kinetochore complex

treatment

NCBI chrNW_004955462:13,082,874...13,142,709
Ensembl chrNW_004955462:13,082,047...13,142,944

G

signal transducer and activator of transcription 5A

disease_progression
treatment

DNA:CNV: :prostate (human)

NCBI chrNW_004955451:16,305,363...16,319,219
Ensembl chrNW_004955451:16,305,363...16,318,534

G

tripartite motif containing 24

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955494:4,308,924...4,421,588
Ensembl chrNW_004955494:4,308,924...4,370,160

G

zinc finger protein 217

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955445:5,326,905...5,337,573

G

zinc finger protein 367

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955422:23,516,950...23,535,882
Ensembl chrNW_004955422:23,517,185...23,586,694

Familial Prostate Cancer

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

adhesion G protein-coupled receptor G1

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955433:15,253,196...15,288,982
Ensembl chrNW_004955433:15,259,720...15,289,151

G

androgen receptor

ClinVar Annotator: match by term: Prostate cancer susceptibility

PMID:8530589 PMID:10589774 PMID:11103816 PMID:28492532

NCBI chrNW_004955475:7,013,960...7,192,473
Ensembl chrNW_004955475:7,013,960...7,186,069

G

Rho GTPase activating protein 6

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955544:1,619,742...2,095,314
Ensembl chrNW_004955544:1,620,838...2,095,220

G

alpha tubulin acetyltransferase 1

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955583:643,575...652,393

G

ATM serine/threonine kinase

ClinVar Annotator: match by term: Familial prostate cancer

PMID:15928302 PMID:16199547 PMID:16941484 PMID:17124347 PMID:17910737 More...

NCBI chrNW_004955412:10,422,753...10,531,406
Ensembl chrNW_004955412:10,426,135...10,530,545

G

beta-1,3-glucuronyltransferase 1

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955412:35,294,434...35,321,873
Ensembl chrNW_004955412:35,294,434...35,321,851

G

brain enriched myelin associated protein 1

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955445:4,951,645...5,049,925
Ensembl chrNW_004955445:4,951,433...5,055,238

G

BCL2 apoptosis regulator

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955402:46,911,125...47,084,214
Ensembl chrNW_004955402:46,916,266...47,084,485

G

BCL2 like 11

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955470:2,740,682...2,780,225

G

bridge-like lipid transfer protein family member 3A

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955437:2,844,544...2,905,073
Ensembl chrNW_004955437:2,875,835...2,904,114

G

BRCA1 DNA repair associated

ClinVar Annotator: match by term: Familial prostate cancer

PMID:17319787 PMID:18489799 PMID:20104584 PMID:21203900 PMID:25525159 More...

NCBI chrNW_004955451:16,819,463...16,870,780
Ensembl chrNW_004955451:16,819,023...16,855,528

G

BRCA2 DNA repair associated

ClinVar Annotator: match by term: Familial prostate cancer | ClinVar Annotator: match by term: Hereditary prostate cancer

PMID:186727 PMID:8524414 PMID:8665505 PMID:9012404 PMID:9150154 More...

NCBI chrNW_004955431:13,449,287...13,526,878
Ensembl chrNW_004955431:13,449,543...13,527,432

G

caspase 8

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955403:322,082...348,591
Ensembl chrNW_004955403:322,555...347,053

G

cell division cycle associated 7

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955449:1,912,125...1,923,026
Ensembl chrNW_004955449:1,912,064...1,923,886

G

cadherin 1

ClinVar Annotator: match by term: Hereditary prostate cancer | ClinVar Annotator: match by term: Prostate cancer susceptibility

PMID:11948460 PMID:14961571 PMID:15235021 PMID:16061854 PMID:16189707 More...

NCBI chrNW_004955484:7,782,409...7,861,082
Ensembl chrNW_004955484:7,782,772...7,860,967

G

cyclin dependent kinase inhibitor 1B

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955413:9,615,542...9,620,542
Ensembl chrNW_004955413:9,615,542...9,620,542

G

chromodomain helicase DNA binding protein 3

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955467:9,024,112...9,050,062
Ensembl chrNW_004955467:9,029,265...9,050,718

G

checkpoint kinase 2

ClinVar Annotator: match by term: Familial prostate cancer | ClinVar Annotator: match by term: Hereditary prostate cancer | ClinVar Annotator: match by term: Prostate cancer susceptibility

PMID:9536098 PMID:12454775 PMID:12610780 PMID:15095295 PMID:15818573 More...

NCBI chrNW_004955455:2,969,113...3,008,004
Ensembl chrNW_004955455:2,969,270...3,003,173

G

collagen type XXIII alpha 1 chain

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955408:1,771,547...2,034,458
Ensembl chrNW_004955408:1,778,061...2,033,526

G

chromosome unknown C11orf65 homolog

ClinVar Annotator: match by term: Familial prostate cancer

PMID:15928302 PMID:16941484 PMID:17124347 PMID:17910737 PMID:19431188 More...

NCBI chrNW_004955412:10,533,174...10,567,364
Ensembl chrNW_004955412:10,533,441...10,567,612

G

DENN domain containing 4B

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955545:526,057...541,118
Ensembl chrNW_004955545:523,705...541,118

G

DNA methyltransferase 3 beta

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955422:28,380,595...28,427,012
Ensembl chrNW_004955422:28,380,591...28,421,301

G

dedicator of cytokinesis 2

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955408:22,630,375...23,059,832
Ensembl chrNW_004955408:22,630,364...23,059,899

G

EMSY transcriptional repressor, BRCA2 interacting

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955414:15,395,851...15,482,490
Ensembl chrNW_004955414:15,401,664...15,477,828

G

fibrosin like 1

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955482:442,043...501,579

G

HAUS augmin like complex subunit 6

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955434:21,516,668...21,557,565
Ensembl chrNW_004955434:21,515,274...21,557,641

G

homeobox B13

ClinVar Annotator: match by term: Prostate cancer susceptibility

PMID:8756292 PMID:15964834 PMID:17138648 PMID:22236224 PMID:22714738 More...

NCBI chrNW_004955451:12,536,415...12,538,169
Ensembl chrNW_004955451:12,536,415...12,538,169

G

inner centromere protein

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955511:5,705,948...5,724,167
Ensembl chrNW_004955511:5,706,201...5,720,772

G

integrin subunit beta 8

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955410:23,011,874...23,099,191
Ensembl chrNW_004955410:23,011,973...23,097,021

G

lysine demethylase 2A

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955422:18,201,243...18,308,163
Ensembl chrNW_004955422:18,200,758...18,308,163

G

kinetochore scaffold 1

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955416:7,498,983...7,561,620
Ensembl chrNW_004955416:7,500,415...7,562,273

G

La ribonucleoprotein 4B

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955492:113,900...197,753
Ensembl chrNW_004955492:138,374...193,145

G

HLA class II histocompatibility antigen, DO alpha chain

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955437:1,603,395...1,606,800
Ensembl chrNW_004955437:1,603,168...1,607,134

G

mitotic arrest deficient 1 like 1

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955460:9,340,728...9,672,478
Ensembl chrNW_004955460:9,340,681...9,672,134

G

mitogen-activated protein kinase kinase 1

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955450:9,181,851...9,205,277
Ensembl chrNW_004955450:9,181,851...9,239,648

G

methyl-CpG binding domain protein 2

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955402:38,761,668...38,829,830
Ensembl chrNW_004955402:38,767,419...38,830,204

G

muscleblind like splicing regulator 1

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955448:3,864,862...4,065,122
Ensembl chrNW_004955448:3,864,843...4,065,122

G

MDS1 and EVI1 complex locus

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955448:18,259,847...18,542,085
Ensembl chrNW_004955448:18,259,083...18,439,646

G

matrix metallopeptidase 14

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955409:37,438,924...37,448,704
Ensembl chrNW_004955409:37,440,541...37,448,437

G

MOB kinase activator 2

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955476:10,840,727...10,906,726
Ensembl chrNW_004955476:10,840,718...10,910,265

G

mutS homolog 6

ClinVar Annotator: match by term: Hereditary prostate cancer

PMID:18269114 PMID:24362816 PMID:25741868 PMID:28492532

NCBI chrNW_004955441:14,451,207...14,471,316
Ensembl chrNW_004955441:14,451,307...14,471,227

G

myosin IXB

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955524:973,576...1,024,351
Ensembl chrNW_004955524:974,844...1,024,311

G

paired box 9

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955409:24,401,599...24,443,687
Ensembl chrNW_004955409:24,424,343...24,444,040

G

PBX/knotted 1 homeobox 2

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955412:26,214,671...26,468,737
Ensembl chrNW_004955412:26,372,846...26,468,926

G

POU class 2 homeobox 2

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955555:759,308...793,500
Ensembl chrNW_004955555:759,308...793,485

G

PPFIA binding protein 2

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955414:23,269,050...23,418,804
Ensembl chrNW_004955414:23,270,072...23,419,523

G

Ras association domain family member 3

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955458:11,400,655...11,451,796
Ensembl chrNW_004955458:11,441,054...11,449,423

G

regulatory factor X7

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955409:59,535...121,157
Ensembl chrNW_004955409:59,536...118,315

G

ribonuclease L

ClinVar Annotator: match by term: Prostate cancer susceptibility

PMID:12415269 PMID:16609730 PMID:25741868

NCBI chrNW_004955406:21,413,950...21,424,860
Ensembl chrNW_004955406:21,411,980...21,425,052

G

ring finger protein 43

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955451:4,604,985...4,680,762
Ensembl chrNW_004955451:4,604,985...4,680,762

G

renalase, FAD dependent amine oxidase

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955425:4,368,620...4,667,947

G

succinyl-CoA:glutarate-CoA transferase

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955460:2,866,466...3,559,625
Ensembl chrNW_004955460:2,866,877...3,559,615

G

transcription factor 4

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955402:39,735,596...40,066,151
Ensembl chrNW_004955402:39,735,600...40,066,151

G

transcription factor 7 like 2

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955431:18,020,309...18,207,926
Ensembl chrNW_004955431:18,020,409...18,209,134

G

torsin family 1 member A

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955513:30,655...36,299
Ensembl chrNW_004955513:30,655...36,360

G

teashirt zinc finger homeobox 1

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955402:58,695,150...58,717,926

G

tetratricopeptide repeat domain 28

CTD Direct Evidence: marker/mechanism

NCBI chrNW_004955455:2,322,290...2,964,259
Ensembl chrNW_004955455:2,325,010...2,747,519

prostate adenocarcinoma

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

adiponectin, C1Q and collagen domain containing

susceptibility

DNA:SNPs, haplotypes:5' utr, introns, exon:multiple

NCBI chrNW_004955420:20,911,181...20,922,992
Ensembl chrNW_004955420:20,912,348...20,914,402

G

adiponectin receptor 1

susceptibility

DNA:SNPs, haplotype:intron, exon: (rs12733285, rs7539452) (human)

NCBI chrNW_004955406:38,939,167...38,955,647
Ensembl chrNW_004955406:38,936,588...38,955,352

G

AKT serine/threonine kinase 1

treatment

NCBI chrNW_004955538:3,208,711...3,224,386
Ensembl chrNW_004955538:3,208,710...3,229,904

G

AKT serine/threonine kinase 2

treatment

NCBI chrNW_004955578:950,258...1,004,438
Ensembl chrNW_004955578:967,593...1,004,438

G

AKT serine/threonine kinase 3

treatment

NCBI chrNW_004955406:6,907,876...7,163,672

G

androgen receptor

treatment

NCBI chrNW_004955475:7,013,960...7,192,473
Ensembl chrNW_004955475:7,013,960...7,186,069

G

bridging integrator 1

NCBI chrNW_004955459:3,376,149...3,423,157
Ensembl chrNW_004955459:3,399,611...3,422,621

G

baculoviral IAP repeat containing 6

ameliorates

mRNA:increased expression:prostate gland (human)

NCBI chrNW_004955441:740,299...923,920
Ensembl chrNW_004955441:739,567...922,959

G

baculoviral IAP repeat containing 7

exacerbates

mRNALincreased expression:prostate gland (human)

NCBI chrNW_004955528:919,246...922,581
Ensembl chrNW_004955528:919,246...922,619

G

B-Raf proto-oncogene, serine/threonine kinase

NCBI chrNW_004955494:2,567,238...2,712,708

G

calcium/calmodulin dependent protein kinase II inhibitor 1

treatment

NCBI chrNW_004955452:1,044,696...1,046,657
Ensembl chrNW_004955452:1,043,459...1,046,669

G

cyclin B1

severity

NCBI chrNW_004955446:140,661...149,500
Ensembl chrNW_004955446:140,093...149,500

G

cyclin E2

NCBI chrNW_004955417:11,027,749...11,039,945
Ensembl chrNW_004955417:11,027,749...11,040,017

G

CD9 molecule

disease_progression

DNA, mRNA:deletion, point mutation, decreased expression:prostate gland

NCBI chrNW_004955413:3,891,874...3,924,065
Ensembl chrNW_004955413:3,891,874...3,928,119

G

chromodomain helicase DNA binding protein 4

mRNA:decreased expression:prostate gland (human)

NCBI chrNW_004955413:4,191,619...4,228,225
Ensembl chrNW_004955413:4,191,619...4,228,225

G

component of inhibitor of nuclear factor kappa B kinase complex

treatment

NCBI chrNW_004955507:6,066,026...6,102,066
Ensembl chrNW_004955507:6,067,203...6,102,001

G

clusterin

treatment

NCBI chrNW_004955403:50,160,598...50,175,876
Ensembl chrNW_004955403:50,160,598...50,175,876

G

cAMP responsive element binding protein 3 like 4

PMID:11830526 PMID:17270658

RGD:13504714 RGD:13504715

NCBI chrNW_004955545:563,710...569,224
Ensembl chrNW_004955545:564,193...568,942

G

catenin beta 1

ClinVar Annotator: match by term: Prostate adenocarcinoma

PMID:10192393 PMID:25741868 PMID:26619011

NCBI chrNW_004955420:29,030,716...29,047,447
Ensembl chrNW_004955420:29,030,716...29,047,449

G

DNA methyltransferase 1

mRNA,protein:increased expression:prostate gland:

NCBI chrNW_004955495:1,465,529...1,505,379
Ensembl chrNW_004955495:1,465,480...1,505,462

G

DNA methyltransferase 3 alpha

mRNA:increased expression:prostate gland:

NCBI chrNW_004955469:7,264,431...7,367,059
Ensembl chrNW_004955469:7,269,952...7,367,059

G

DNA methyltransferase 3 beta

mRNA,protein:increased expression:prostate gland:

NCBI chrNW_004955422:28,380,595...28,427,012
Ensembl chrNW_004955422:28,380,591...28,421,301

G

fibroblast growth factor 2

disease_progression

NCBI chrNW_004955428:17,840,554...17,894,779
Ensembl chrNW_004955428:17,840,628...17,894,773

G

fibroblast growth factor receptor 1

PMID:18068632 PMID:23576558

RGD:13504748 RGD:2298702

NCBI chrNW_004955463:14,013,247...14,064,354
Ensembl chrNW_004955463:14,013,247...14,064,111

G

growth factor receptor bound protein 2

NCBI chrNW_004955553:2,186,590...2,258,964
Ensembl chrNW_004955553:2,186,590...2,259,456

G

HRas proto-oncogene, GTPase

ClinVar Annotator: match by term: Adenocarcinoma of prostate | ClinVar Annotator: match by term: Prostate adenocarcinoma

PMID:1904555 PMID:3510078 PMID:11150980 PMID:16155195 PMID:16170316 More...

NCBI chrNW_004955476:11,508,446...11,510,333
Ensembl chrNW_004955476:11,508,126...11,510,333

G

isocitrate dehydrogenase (NADP(+)) 1

ClinVar Annotator: match by term: Prostate adenocarcinoma

PMID:18772396 PMID:19657110 PMID:19798509 PMID:19818334 PMID:20946881 More...

NCBI chrNW_004955457:6,851,542...6,869,452
Ensembl chrNW_004955457:6,851,517...6,872,367

G

insulin like growth factor 1 receptor

treatment
disease_progression

PMID:8692980 PMID:25442907 PMID:25862373 PMID:26452103

RGD:13504753 RGD:13504767 RGD:13504768 RGD:13504771

NCBI chrNW_004955416:26,101,090...26,382,660
Ensembl chrNW_004955416:26,102,628...26,382,666

G

inhibitor of nuclear factor kappa B kinase subunit beta

treatment

NCBI chrNW_004955536:611,965...658,647
Ensembl chrNW_004955536:612,774...658,647